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1. Amyotrophic Lateral Sclerosis (ALS) 
???????????????????????????????????????????????????????????????????????????????????????
most common neurodegenerative disorders, described for the first time by Jean-Martin 
Charcot in 1874. The pathology incidence is of 4-6 per 100.000 and the average age of 
onset is 50 years, but juvenile cases are also observed. The most typical feature of this 
progressive lethal disease is the degeneration of cortical, bulbar and spinal motor 
neurons, except for the neurons that control the bladder and the oculo-motoneurons 
(Fig. 1). This leads to generalized muscle weakness, fasciculations, muscle atrophy, 
speech and swallowing disabilities, progressive paralysis and, ultimately, death caused 
by respiratory failure (Bendotti et al., 2004). ALS may present as a predominantly lower 
motor neuron (LMN) form designates progressive muscular atrophy (PMA), a 
predominantly upper lower motor neuron (UMN) form called primary lateral sclerosis 
(PLS), or more commonly with mixed UMN and LMN deficits (Hand et al., 2002).  
 
 
Fig. 1. Motor neurons involved in ALS and the consequent muscle atrophy. 
 
Approximately 10% of ALS cases are inherited (familial ALS, FALS) and in the vast 
majority of patients, ALS is sporadic (SALS), although many cases labelled as sporadic 
may well have a family history (Andersen et al., 2011). Furthermore, SALS and FALS 
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are clinically indistinguishable and all genes found mutated in FALS cases have also 
been found mutated in SALS (Bendotti et al., 2004, Andersen et al., 2011). The 
male:female ratio is 1:1 in FALS and 1.7:1 in SALS, although this value decreases 
which increasing age at presentation, approaching 1:1 after 70 years of age. The 
duration of FALS is bimodal; a small percentage of patients have poor prognosis, with 
an average survival of < 2 years, whereas the remainder have a better prognosis than 
sporadic cases, with survival usually > 5 years (Hand et al., 2002). The development of 
effective therapeutics for ALS has been disappointing. Riluzole is the only approved 
medication shown in randomized controlled trials to benefit patients with SALS 
(Bensimon et al., 1994; Lacomblez et al., 1996). It is a neuroprotective drug that blocks 
glutamatergic neurotransmission in the CNS (Doble, 1996) but it has limited therapeutic 
benefits with minimal effects on survival (Miller et al., 2008) and no effect on muscle 
strength, quality of life or functional capacity (Lacomblez et al., 1996); it prolongs life by 
only 2 to 3 months (Miller et al., 2007). Other trials in the past year gave negative 
results, including lithium in combination with riluzole (Aggarwal et al., 2010), valproic 
acid (Piepers et al., 2009) and coenzyme Q10 (Kaufmann et al., 2009). In addition to 
pharmacotherapy, there are promising early developments with therapeutic implications 
in the areas of (i) RNA interference, (ii) stem cell therapies, (iii) viral vector-mediated 
gene therapy and (iiii) immunotheraphy (Mitsumoto et al., 2010).  
(i) RNA interference (RNAi) is a process in which non coding miRNA inhibits and 
regulates gene expression by binding mRNA (Mello et al., 2004). This endogenous 
silencing mechanism is now being used to study its therapeutic application to autosomal 
dominant (heterozygous) disease that might be cured by effective silencing of the 
dominant mutant allele. Specific genes are experimentally target for silencing through 
the administration of siRNA produced in vitro, or miRNA using viral vectors.  
(ii) Stem cell therapies might halt or slow the progression of motor neuron disease, by 
providing growth factors to host tissue, immunomodulation of host environment, anti-
inflammatory effects of microglia and astrocytes, or even by replacing motor neurons or 
having trophic effects on neurons and neighboring cells. Several stem cell sources have 
been studied in ALS, including bone marrow transplant, mesenchymal stem cell (MSC) 
transplant, neural stem cell transplant, astrocyte precursor transplant, and induced 
pluripotent stem cells (iPSCs). 
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(iii) In diseases with identified genetic defects, there is ongoing research into using 
targeted gene therapy using viral vectors to improve abnormal protein synthesis. 
Whereas the large majority of human ALS is sporadic and without known mutation, 
another motor neuron disease, SMA, has a well defined genetic defect in the SMN1 
gene. In 2010, Passini et al. described the use of a viral vector expressing human SMN 
that was injected into a mouse model of SMA. They described the successful 
expression of SMN in the mouse spinal cord, improved myofiber size and 
neuromuscular junction architecture, improvement in tests of muscle strength, and 
prolonged survival. This study is promising as a model for gene therapy in diseases of 
known genetic mutation and protein deficiency. 
(iiii) Whereas RNAi therapy seems to reduce production of abnormal protein at 
transcriptional level, other studies are focusing on the use of antibody-mediated therapy 
to reduce the amount of abnormal protein. In follow-up to an earlier study demonstrating 
increased survival and delayed disease onset with SOD1 immunization (Urushitani et 
al., 2007), in other studies two monoclonal antibodies were tested against mutant SOD1 
through passive intraventricular infusion in a mouse model (Gros Louis et al., 2010). 
One of the antibodies reduced the amount of mutant SOD1 in the spinal cord and 
prolonged survival. Passive antibody therapies may be safer but require further study.  
 
2. Aetiology 
Amyotrophic lateral sclerosis is likely to be a multifactorial and multisystem disease. The 
pathogenic mechanisms that underlie ALS remain largely unclear, but a large spectrum 
of aetiological factors have been considered including genetics, environmental factors, 
oxidative stress, glutamate excitotoxicity, mitochondrial damage, defective axonal 
transport, protein aggregation with TAR DNA-binding protein 43 as major constituent of 
the ubiquitinated protein inclusions found in surviving motor neurons in most forms of 
ALS, viral infection. Recently there has been growing interest in the role played by non-
neuronal neighbourhood cells in the pathogenesis of motor neuron injury. Actually ALS 
is considered also a glial pathology and disruption of glial cell?motor neuron 
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2.1 Environmental factors 
Epidemiological studies demonstrate that there is a link between environmental factors 
and the onset of ALS. Environmental factors that have been associated with ALS risk 
include cigarette smoking (Chiba and Masironi, 1992; Weisskopf et al., 2004), exposure 
to heavy metals (Campbell et al., 1970; McGuire et al.; 1997; Kamel et al., 2002) and 
pesticides (Savettieri et al., 1991), intensive physical activity (Cruz et al., 1999; 
Longstreth, 1998; Chiò et al., 2005) and head injuries (Chen et al., 2007). A prospective 
study based on ALS mortality data found that an association with cigarette smoking was 
restricted to women (Weisskopf et al., 2005). Most of these factors have not been 
consistently implicated, but show variation in results across different studies. 
Nonetheless, there are indications that there may be causal links between different 
environmental toxicant, and a need for more research (Johnson and Atchison 2009; 
Schmidt et al., 2011). 
 
2.2 Genetic factors 
Although the underlying cause of the sporadic form of ALS remains unclear, progress in 
our understanding of disease mechanisms has been made through research into 
familial forms of ALS, which constitute 10% of cases (Bruijn et al., 2004). 
Our understanding of the molecular and cellular pathology of ALS has progressed 
greatly since 1993, with the discovery that mutations in the gene coding for the Cu/Zn 
superoxide dismutase 1 (SOD1) underlie approximately 20% of FALS cases (Rosen, 
1993). Mutations are inherited as an autosomal dominant trait (Deng et al., 1993). 
Subsequently, different Mendelian loci have been linked to FALS and several causative 
genes have been identified (Dion et al., 2009), including: ALSIN, that functions as an 
exchange factor for a small GTPase which regulates endosomal trafficking (Yang et al., 
2001); VAPB, that encodes a vescicle-associated membrane protein-associated protein 
B (Nishimura et al., 2004); SETX, that encodes a DNA/RNA helicase (Chen et al., 
2004); ANG, that causes a reduced neuroprotective activity against hypoxic injury 
(Greenway et al., 2006) and DCTN1, that is a component of the dynein complex that 
comprises the major axonal retrograde motor (Puls et al., 2003). Recently, much 
attention has been devoted to a gene coding for a DNA/RNA binding protein which has 
been implicated in the pathogenesis of ALS. In fact, a major shift in our understanding 
of ALS pathogenesis started in 2006 (Neumann et al., 2006; Arai et al., 2006) with the 
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identification of the 43 kDa transactive response (TAR) DNA-binding protein (TDP-43) 
as the main component of ubiquitinated protein aggregates found in sporadic ALS 
patients. 
Dominant mutations in the TARDBP gene, which codes for TDP-43, were reported by 
several groups as a primary cause of ALS for 3% familial cases and 1.5% sporadic 
cases (Corrado et al., 2009; Kabashi et al., 2008). A list of genes involved in ALS is 
provided in Table 1. 
 
 
Table 1. Established ALS-associated genes as of June 2011 (Andersen and Al-Chalabi, 2011) 
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3 Superoxide dismutase 1 (SOD1) 
3.1 Structure and function 
Eukaryotic cells express three distinct forms of SOD. SOD 1 (Cu/Zn-SOD) is encoded 
on chromosome 21 (21q22.1)(Fig. 2) and localized to the cytoplasm. SOD 2 (Mn-SOD) 
is encoded on chromosome 6 and is located in the mitochondrial matrix, while SOD 3 
(Fe-SOD) is an extracellular protein (Rosenfield et al., 1997).  
 
 
Fig. 2. SOD1 gene position on chromosome 21 
 
SOD1 is an abundant protein in the CNS, accounting for about 1% of brain protein, but 
it is also ubiquitously expressed in all other tissues (Shaw et al., 2005). The product of 
the SOD1 gene, is a major antioxidant enzyme located predominantly in the cytosol, 
nucleus, and mitochondrial intermembrane space (IMS) of eukaryotic cells and in the 
periplasmic space of bacteria (Lyons et al., 1999; Matsumoto et al., 2001). The 
eukaryotic enzyme is a 32 kDa homodimer with a highly conserved amino acid 
sequence, and it contains one copper and one zinc-binding site, as well as a disulfide 
bond in each of its two subunits.  
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Fig. 3. The X-ray crystallographic structure of SOD1 
 
Each of the two subunits of SOD1 forms an eight-stranded Greek key ?-barrel and 
contains an active site that binds a catalytic copper ion (binding residues: His46, His48, 
His63 and His120) and a structural zinc ion (binding residues: His63, His71, His80 and 
Asp83) (Banci et al., 2008). The zinc ion is bound to three histidine residues and one 
aspartate residue. The copper atom is bound to four histidine residues. The two metal 
ions are connected via a histidine bridge (Fig. 4). 
 
 
Fig. 4. Active site of SOD1 
SOD1 catalyzes the disproportionation of superoxide, yielding hydrogen peroxide and 
dioxygen, thus reducing steady-state levels of superoxide in its surroundings, 
preventing the further generation of reactive oxygen species (ROS) (Dion et al., 2009). 
Attention has been focused on how mutations could affect these steps of SOD1 
maturation. The mature, correctly folded and enzymatically active form of SOD1 is 
obtained in vivo through several post-translational modifications: acquisition of zinc and 
copper ions, disulfide bond formation, and dimerization (Culotta et al., 2006; Farnesano 
et al., 2004). 
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3.2 SOD1 mutations 
To date, over 150 different mutations (mostly missense mutations) have been 
discovered in the SOD1 gene that account for 20% familial cases. Most of the individual 
mutations result in substitution of one single amino acid by another; such substitutions 
have been identified at over one third of the 153 amino acid residues of the wild-type 
Cu/Zn SOD protein. In addition to the individual amino acid substitutions, there are also 
a smaller group of mutations resulting in amino acid deletions and truncations. The 
mutations encompass all coding regions of the gene affecting over 70 positions with 
preponderance for exons 4 and 5 (Fig. 5).  
 
 
Fig. 5. Schematic diagram of human SOD1 primary sequence with exons, introns, metal binding domains 
(Cu, Zn), intramolecular disulfide bond (SH) and mutations linked to sporadic and familial ALS. Mutations 
are distributed throughout all exons with high prevalence in exons 4 and 5.No clear structure?function 
relationship to FALS appears evident. Mutation legend: grey, missense; purple, insertion; red, deletion; 
blue/green, silent; (D) in frame deletion; X, truncation (Turner and Talbot, 2008).  
 
The mutations include some 110 missense, 8 nonsense, 7 sense and 3 in frame 
deletions in the coding sequence. Another 7 mutations occur in non coding sequence 
predicting aberrant mRNA splicing, although the precise functional effects of some of 
these mutations remains unclear (Restagno et al., 2005). Furthermore, the silent 
mutations are assumed to be non-pathogenic, although new data implicating the SOD1 
transcript in ribonuclear protein complex stability suggests a plausible role for these 
variants in disease (Ge et al., 2006). Thus, the majority of SOD1 mutations encode 
polypeptides with single amino acid substitutions and a subset with C-terminal 
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truncation. All SOD1 mutations associate with dominant ALS, with the exception of 
N86S and D90A substitutions which also behave as recessive traits (Andersen et al., 
1995; Hayward et al., 1998), although the former mutation was described in rare 
juvenile onset ALS. Compound mutations involving D90A and D96N were also reported 
in recessive FALS (Hand et al., 2001). SOD1-linked FALS is clinically heterogeneous 
both within and between affected families (Cudkowicz et al., 1997), hampering efforts to 
correlate disease onset and severity with mutation. Factors contributing to this include 
incomplete, low or age dependent penetrance and clinical anticipation (Iwai et al., 2002; 
Andersen, 2006). However, the most severe and prevalent mutation in America, A4V, 
reliably predicts short survival (Cudkowicz et al., 1997), while D90A, the most common 
SOD1 mutation worldwide and in the sporadic population, correlates with non-penetrant 
or slowly progressive disease (Andersen, 2006). Interestingly, D90A was first regarded 
as a neutral polymorphism in northern Scandinavian heterozygotes (Sjalander et al., 
1995); however, homozygosity was later established in FALS pedigrees (Andersen et 
al., 1995). Remarkably, patients heterozygous for D90A were then discovered in the 
Belgian population (Robberecht et al., 1996), suggesting a protective haplotype in the 
??????????????? ????? ????????? ???????????? ???? ????? ??????????? ????? ????? ?? ???????
founder over 1000 years ago (Al-Chalabi et al., 1998) and is a linked to a cis-acting 
protective genetic factor presumed to be non coding SOD1 mutation (Parton et al., 
2002), attempts at which to define have been unsuccessful to date. Curiously, only a 
single SALS patient with a de novo SOD1 mutation (H80A) has been reported 
(Alexander et al., 2002). This suggests that the strict division of FALS and SALS is 
problematic. In the absence of parental genotypes, an isolated case of ALS may be 
apparent SALS, dominant FALS with a low penetrant or de novo mutant SOD1 allele or 
recessive FALS as expertly reviewed recently (Andersen et al., 2006). It is important to 
note that some SOD1 mutations do not co-segregate with disease and carriers can 
remain asymptomatic throughout life, suggesting that not all SOD1 mutations cause 
ALS and some are rather polymorphisms. The clinical phenotype associated with a 
given mutation in the SOD1 gene is clearly not only dependent on the mutation itself, 
but may also be influenced by the genetic background of the patient, and possibly by 
environmental factors (Hayward et al., 1998). To date, there is no conclusive 
explanation on how mutations in the SOD1 gene cause ALS. Initially, it was 
hypothesized that mutations would impair the enzymatic activity of the protein, thus 
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resulting in increased cellular levels of reactive oxygen species, oxidative stress, and 
neuronal death (Deng et al., 1993). However, it has subsequently been shown that 
some mutants retain full catalytic activity, and that there is no correlation between 
residual enzymatic activity, clinical progression, and disease phenotype (Radunovic et 
al., 1997). Additional evidence against a loss-of-function hypothesis comes from animal 
models: SOD1 knockout mice do not develop motor neuron disease (Reaume et al., 
1996), while transgenic mice (Gurney et al., 1994) and rats (Nagai et al., 2001) over-
expressing the human mutant SOD1 gene do. Also, the expression of mutant SOD1 
alleles in cell culture models induces apoptosis in neurons (Pasinelli et al., 1998). In 
both in vitro and in vivo models, dismutase activity appears to be normal or elevated, 
suggesting that SOD1 mutations may result into the acquisition of a novel function, toxic 
to motor neurons (gain-of function hypothesis). Several studies showed that mutant 
SOD1 is prone to misfolding and forms cytoplasmic aggregates. In turn, aggregates 
may lead to cell death by sequestering other cytoplasmic proteins essential for neuronal 
survival, by clogging the ubiquitin/proteasome system, by chaperones depletion, or by 
disrupting mitochondria, cytoskeleton and/or axonal transport (Ticozzi et al., 2011). The 
aggregation hypothesis is particularly attractive because protein aggregates are 
frequently associated with neurodegenerative diseases and are also observed in ALS 
(Bendotti et al., 2004). The discovery of mutations linked with fALS has made possible 
the development of aetiological models of the disease.  
 
4. ALS10 and TDP-43 
4.1 Structure and function of TDP-43 
TARDBP, the gene encoding TDP-43, is located on chromosome 1p36.22, and is 
comprised of six exons (exon 1 is non-coding and of unknown function; exons 2?6 are 
protein coding) and is evolutionarily highly conserved. Cross-species comparisons of 
TDP-43 proteins from human, mouse, Drosophila melanogaster, and Caenorhabditis 
elegans showed a high degree of aminoacid sequence conservation (Ayala et al., 2005; 
Sreedharan et al., 2008).  
The structure of TDP-43 was shown to resemble members of the heterogeneous 
ribonucleoprotein (hnRNP), RNA binding proteins, family (Lagier-Tourenne et al., 2010). 
TDP-43 contains five functional domains, which are illustrated in Figure 6. There are 
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two RNA recognition motifs (RRM1 and RRM2) and the greatest homology among 
species was shown to exist within these domains (Ayala et al., 2005). This suggests 
that proteins from human, mouse, worm and fly all share equivalent RNA and DNA 
recognition specificity. Further, these RRM domains have two highly conserved 
hexameric ribonucleoprotein 2 (RNP2), and octameric ribonucleoprotein (RNP1) 
regions, which are involved in binding to the TAR DNA sequence of HIV-1 and RNA 
sequences with UG repeats (Kuo et al., 2009). TDP-43 has a nuclear export signal 
(NES) and a nuclear localization signal (NLS) enabling it to shuttle between the nucleus 
and the cytoplasm, potentially transporting bound mRNAs (Banks et al., 2008). TDP-43 
protein also has a glycine-rich sequence at the C-terminal, which has been shown to 
mediate protein?protein interactions (Lagier-Tourenne et al., 2010). However, this 
domain varies significantly between species and the low homology is presumed to 





Fig. 6. Schematic diagram of the TARDBP gene and TDP-43 protein. Exon 1 of TARDBP is non-coding 
and exons 2?6 are protein coding. TDP-43 contains five known functional domains: nuclear localisation 
signal (NLS), nuclear export signal (NES), two RNA recognition motifs (RRM1 and RRM2) and a glycine-
rich C-terminal region. Each RRM has two highly conserved regions, ribonucleoprotein 1 (RNP1) and 
ribonucleoprotein 2 (RNP2) (Warraich et al., 2010). 
 
TDP-43 is a ubiquitously expressed protein in rodents and humans, with a possible 
species-specific difference in expression levels. Northern analysis showed that 
expression levels of human TDP-43 mRNA are heterogeneous among a variety of 
tissues, including pancreas, spleen, placenta, ovary, testis, lung, prostate, small 
intestine, kidney, colon, thymus, brain, and liver (Ou et al., 1995). TDP-43 is 
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predominantly localized to the nucleus with low levels in the cytoplasm (Banks et al., 
2008). TDP-43 and some observed C-terminal fragments of the protein are degraded by 
both the ubiquitin proteasome system (UPS) and the autophagy-lysosomal pathway 
(ALP). Inhibition of the UPS or ALP was shown to cause cytoplasmic accumulation of 
TDP-43 in cell culture (Wang et al., 2010). TDP-43 has been found to associate with the 
ubiquitin-like protein, Ubiquilin 1, and binds and regulates the expression of histone 
deacetylase 6 (HDAC6), a protein associated with autophagasomal degradation (Fiesel 
et al., 2010; Lagier-Tourenne et al., 2010). 
Most of the mutations identified are localized in the glycine-rich region encoded by exon 
6. All the mutations are dominant missense changes with the exception of a truncating 
mutation at the extreme C-terminal of the protein (Y374X) (Daoud et al., 2009). Several 
variants lying in the non-coding regions of the TARDBP gene have been identified in 
patients but further studies are necessary to prove their pathogenic effect (Luquin et al., 
2009; Gitcho et al., 2009). TDP-43 inclusions are not restricted to motor neurons but 
can be widespread in brain in ALS patients with or without dementia (Yokoseki et al., 
2008; Van Deerlin et al., 2008; Pamphlett et al., 2009; Geser et al., 2008; Giordana et 
al., 2009). 
Under normal conditions, TDP-43 is mainly localized within the nucleus, but abnormal 
TDP-43 distribution such as neuronal cytoplasmic or intranuclear inclusions and 
dystrophic neurites (Neumann et al., 2006; Arai et al., 2006), as well as glial cytoplasmic 
inclusions (Arai et al., 2006; Pamphlett et al., 2009; Dickson et al., 2007) have been 
reported. A very curious, and mechanistically unexplained, aspect of TDP-43 pathology 
is a significant TDP-43 nuclear clearance in a proportion of neurons containing 
cytoplasmic aggregates, suggesting that pathogenesis may be driven, at least in part, 
by loss of one or more nuclear TDP-43 functions (Neumann et al., 2006; Van Deerlin et 
al., 2008; Dickson et al., 2007; Igaz et al., 2008; Davidson et al., 2007). Immunoblotting 
of detergent-insoluble protein extracts from affected brain and spinal cord has defined a 
biochemical signature of disease that includes hyperphosphorylation and ubiquitination 
of TDP-43, and the production of several C terminal fragments (CTFs) around 25 kDa 
(Neumann et al., 2006; Arai et al., 2006).  
The precise roles of TDP-43 is not fully elucidated. TDP-43 is structurally close to the 
family of heterogeneous ribonucleoproteins (hnRNPs) and has been involved in multiple 
levels of RNA processing including transcription, splicing, transport and translation (Fig. 
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7). Such multifunctional protein could have roles in coupling transcription with splicing 
and other RNA processes (Andersson et al., 2008; Bertolotti et al., 1999; Tan et al., 
1999). 
 
Fig. 7. Known biological functions of TDP-43. TDP-43 plays multiple roles in RNA processing (highlighted 
in yellow) in the nucleus and the cytoplasm (Warraich et al., 2010). 
 
4.2 Role of TDP-43 in RNA metabolism 
TDP-43 is widely implicated in many different aspects of RNA metabolism, including:  
i) transcription  
TDP-43 was cloned for the first time in 1995 as part of a research aimed at identifying 
novel HIV-1 inhibitors of transcription in correspondence to the TATA element of the 
viral LTR (Ou et al., 1995). The binding site of TDP-43 was identified as a 
polypyrimidine-rich region of the TAR DNA element and was hypothesized to repress 
the recruitment of transcriptional factors to this promoter. Unfortunately no follow up 
work has been reported in this system. More recently, a second promoter where TDP-
43 has been described to play a functional role is in the mouse SP-10 gene, which 
codes for an acrosomal protein, and whose expression is driven by a spermatid specific 
promoter (Lagier-tourenne et al., 2010). Also in this case, TDP-43 seems to mediate 
transcriptional repression in all mouse tissues with the exception of round spermatids 
(Buratti et al., 2010). 
ii) Splicing 
Evidence for a role of TDP-43 in splicing regulation came from the identification of their 
association with other splicing factors and that their depletion or over-expression affects 
the splicing pattern of specific targets. The association of TDP-43 with a number of 
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proteins involved in splicing (Buratti et al., 2005; Freibaum et al., 2010), is consistent 
with its function as a splicing regulator. These interactions are mediated by the C-
terminal glycine-rich domain of TDP-43. Despite evidence that TDP-43 is involved in 
RNA splicing (Buratti et al., 2008; Law et al., 2006), few of its respective RNA targets 
has been identified and a comprehensive protein?RNA interaction map still needs to be 
defined. Recent technologies coupled with high-throughput sequencing have yielded a 
global insight into RNA regulation (Licatalosi et al., 2008; Yeo et al., 2009), and such 
approaches are eagerly anticipated to understand the role of TDP-43 in 
neurodegeneration. Indeed, disrupting the function of an RNA-binding protein can affect 
many alternatively spliced transcripts, and a growing number of neurological diseases 
have been linked to this process. Importantly, splicing alterations (Lin et al., 1998; Rabin 
et al., 2010) and mRNA-editing errors (Kawahara et al., 2004) have been reported in 
sporadic ALS patients. The observation of a widespread mRNA splicing defect in TDP-
43 proteinopathies would reinforce the crucial role of splicing regulation for neuronal 
integrity and potentially identify candidate genes whose altered splicing is central to ALS 
pathogenesis.  
iii) micro-RNA processing 
TDP-43 may play roles in micro-RNA (miRNA) processing. It has been found (by mass 
spectrometry) to associate with Drosha (Gregory et al., 2004), the nuclear RNase III-
type protein that mediates the first step in miRNA maturation (Kim et al., 2009). In 
addition, TDP-43 may be involved in the cytoplasmic cleavage step of miRNA 
biogenesis, mediated by the Dicer complex, as suggested by its association with 
proteins known to participate in these functions (Freibaum et al., 2010). Much more can 
be anticipated soon on the possible involvement of TDP-43 in miRNA processing. 
Increasing evidence suggests that TDP-43 is integral components of RNA stress 
granules (SGs) (Andersson et al., 2008; Freibaum et al., 2010; Wang et al., 2008; 
Nishimoto et al., 2010), cytoplasmic, microscopically visible foci consisting of mRNA 
and RNP complexes that stall translation under stress conditions (Anderson et al., 
2009). The role of these TDP-43-positive SGs remains unknown, but they were 
proposed to mediate the stabilization and transport of the low molecular weight 
neurofilament (NF-L) mRNA to the injury site for local translation of NF-L protein 
required for axonal repair (Strong et al., 2007, Moisse et al., 2009). 
 
 Pagina 15 
Maria Elena Mura 
Molecular mechanisms involved in Amyotrophic Lateral Sclerosis: 
 role of Bcl2-A1 and TDP-43 genes in motor neuron degeneration  
Tesi di dottorato in Scienze Biomolecolari e Biotecnologiche 
Università degli studi di Sassari 
 
4.3 Cytosolic roles of TDP-43 in regulation of RNA subcellular 
localization, translation and decay  
TDP-43 is also present in the cytosol where it is involved in diverse aspects of RNA 
metabolism, regulating the spatiotemporal fate of mRNA, i.e. subcellular localization, 
translation or degradation. Indeed, it has been shown by interspecies heterokaryon 
assays to shuttle between the nucleus and the cytoplasm (Ayala et al., 2008; Zinszner 
et al., 1997). In neurons, TDP-43 is found in RNA transporting granules translocating to 
dendritic spines upon different neuronal stimuli (Elvira et al., 2006; Wang et al., 2008). 
Collectively, these results suggest that both proteins could play a role in the modulation 
of neuronal plasticity by altering mRNA transport and local translation in neurons. The 
role of TDP-43 in the regulation of local translation is less well established; however, it 
has been shown to act as a translational repressor in vitro (Wang et al., 2008) and has 
extensive interactions with proteins participating in translation (Freibaum et al., 2010). 
Increasing evidence suggests that TDP-43 is integral components of RNA stress 
granules (SGs) (Andersson et al., 2008; Freibaum et al., 2010; Wang et al., 2008; 
Nishimoto et al., 2010), cytoplasmic, microscopically visible foci consisting of mRNA 
and RNP complexes that stall translation under stress conditions (Anderson et al., 
2009). TDP-43 is neither essential for formation of SGs nor a neuroprotective factor in 
stress conditions (Colombrita et al., 2009). Nonetheless, in axotomized motor neurons 
in vivo, TDP-43 is found to translocate to the cytoplasm where it formed SGs that 
dissolved after neuronal recovery (Moisse et al., 2009; Sato et al., 2009). The role of 
these TDP-43-positive SGs remains unknown, but they are proposed to mediate the 
stabilization and transport of the low molecular weight neurofilament (NF-L) mRNA to 
the injury site for local translation of NF-L protein required for axonal repair (Strong et 
al., 2007, Moisse et al., 2009). 
 
5 ALS experimental models 
5.1 The SOD1 transgene 
The discovery of gene mutations linked to human ALS has provided opportunities to 
develop model system for investigating mechanism of disease. The first models were 
cellular, mice and rats models mutant in the SOD1 gene. 
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Cellular models of SOD1 related ALS have been generated, which have helped to 
elucidate cellular mechanisms of disease (Shaw et al., 2005). In first models, SOD1 was 
inhibited chronically with either antisense oligodeoxynucleotides or 
diethyldithiocarbamate in spinal cord organotypic cultures. These studies showed that 
chronic inhibition of SOD1 resulted in the apoptotic degeneration of spinal neurons, 
including motor neurons, which. was markedly potentiated by the inhibition of glutamate 
transport (Rothstein et al., 1994). A limit of transient or stable transfection in human or 
mouse cells is the low endogenous gene expression level. This problem was solved by 
means of infection with replication-deficient recombinant adenoviruses. In an in vitro cell 
culture system, it has been shown that infection of mouse NSC-34 motor neuron-like 
cells with adenovirus containing mutant SOD1G93A gene increased cellular oxidative 
stress, mitochondrial dysfunction, cytochrome c release and motor neuron cell death 
(Liu et al., 2002).  
In addition, several transgenic mouse and rat strains were created by the introduction of 
the sequence coding for human mSOD1 under the control of a promoter that enables 
ubiquitous expression of the transgene (Shibata et al., 2001). Unlike SOD1 knockouts, 
transgenic mice and rats with human fALS?SOD1 added to their own enzyme have a 
phenotype that closely resembles ALS (i.e. adult-onset progressive motor paralysis, 
muscle wasting and reduced lifespan). They also express almost all of the essential 
histopathological features of the human disease, including the selective degeneration of 
motor neurons in the spinal cord, the presence of ubiquitinated protein aggregates in 
motor axons and motor neuron perikarya, in addition to the fragmentation of the Golgi 
apparatus in motor neurons and the activation of microglia and astrocytes in the spinal 
cord and brainstem (Shibata et al., 2001). Moreover, several biochemical alterations 
observed in patients, such as the appearance of oxidative-stress markers, alterations of 
mitochondria in motor neurons and muscle and the activation of phosphorylation 
cascades are, in most cases, preserved in these models (Bendotti et al., 2001). There 
are, however, some differences between the various mutant SOD1 mouse strains 
(Valentine et al., 2005) and, depending on the mutation and copy number of the 
transgene, mutant SOD1 transgenic rodents die aged between 4 and 14 months. 
Transgenic mice recapitulate both the phenotype and the histopathology of patients and 
have the obvious advantage of a short lifespan of the animals. All FALS SOD1 rodents 
develop progressive muscular weakness and paralysis until death. Several transgenic 
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lines have been developed, carrying mutations at different positions in SOD1. 
Differences in the age of disease onset among those lines seem to depend 
predominantly on the transgene copy number, whereas the severity of the disease 
depends on the type of mutation. For example, the progression of the disease is much 
more rapid in mice that are transgenic for the G86R mutation of the mouse SOD1 (three 
days) or for the human G85R mutation (7?14 days) than in mice that are transgenic for 
human SOD1G93A (60?110 days) (Shibata et al., 2001). Transgenic mice carrying 20 
copies of SOD1 with the G93A mutation are the most widely studied. Figure 8 
represents the progression of symptoms in these mice, which is preceded and 
paralleled by a sequence of alterations in the structure and function of motor neurons. 
As for many other diseases, the great advantage of an animal model that mimics the 
human pathology is the possibility to follow the stepwise progression of the disease, as 
well as for the design of potential therapeutics. However, the level of expression needed 
in heterozygous patients for mutant SOD1 to exert its toxic effect is much lower than for 
FALS transgenic rodents, in which a 10?30-fold increase of mutant protein level is 
necessary to induce the pathological phenotype. This is due to differences between 
mice and men; differences that should not be overlooked when using mice models 
(Carri et al., 2004). 
 
Fig. 8. Graphic representation of the behavioural and neuropathological progression of the disease in 
superoxide dismutase 1 SOD1G93A transgenic mice. These mice develop the first signs of muscular 
dysfunction around two months of age, with an impairment of the evoked response tested 
electromiographically (EMG). Thereafter, tremors appear in the hind limb, associated with a progressive 
reduction in the extension reflex when the mice are raised by the tail. Atw4 months of age, the mice show 
a progressive muscular weakness starting from the hind limb, revealed by the increasing difficulty to stay 
on a rotating bar and by a reduction in stride length on an inclined ramp. At this stage, more than 50% of 
motor neurons (MN) of the lumbar spinal cord are lost and one month later these mice die. Mitochondrial 
vacuolisation and the swelling of motor neurons are among the earliest events and are accompanied by a 
decreased function of the mitochondria. Later, but still at the asymptomatic stage, the SOD1G93A mice 
show signs of cytoskeletal disorganization in the motor neurons, with the accumulation of phosphorylated 
neurofilaments. The accumulation of detergent-insoluble proteins and ubiquitinated intracellular inclusions 
are particularly evident at advanced stages of the disease. Reactive gliosis, which involves hypertrophy 
and the activation of astrocytes, and the proliferation and activation of microglia, is detectable with the 
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degeneration of motor neurons and becomes prominent when the cell loss is remarkable. Hypertrophic 
astrocytes and reactive microglia are usually located around degenerating motor neurons (Bendotti and 
Carrì, 2004). 
 
5.2 Cellular and animal models for TDP-43 
The role of TDP-43 in the pathogenesis has not been established and both a gain of 
toxic property(ies) and a loss of function via its sequestration in aggregates are 
plausible. For TDP-43 the first outcomes modelling disease in fruit flies or mice have 
produced a confusing story that has not yet settled the key questions concerning mutant 
TDP-43-mediated pathogenesis. Consistently, increased cytoplasmic TDP-43 
localization was found at presymptomatic stages in mice overexpressing wildtype TDP-
43 (Wils et al., 2010) as well as in an acute rat model with adenovirus-mediated wild-
type TDP-43 expression (Tatom et al., 2009).  
In various cell culture experiments, the expression of TDP-43 proteins carrying 
mutations that disrupt its NLS (amino acids 78?84) led to localization primarily within the 
cytoplasm (Barmada et al., 2010; Winton et al., 2008). An elegant study utilized an 
automated microscopy system for long-term visualization and quantitative correlation 
between morphologic changes and survival of individual neurons to show that 
cytoplasmic TDP-43 is toxic for rat primary cortical neurons (Barmada et al., 2010). 
Although overexpression of wild-type TDP-43 led to increased cytoplasmic localization 
of TDP-43 and cell death independently of mutation, pathogenic TDP-43 mutations 
increased the proportion of cytoplasmic TDP-43 (Barmada et al., 2010). On the other 
hand, how forced synthesis of high levels of TDP-43 relates to actual pathogenic 
mechanism for the lower levels of TDP-43 in the physiologically relevant contexts is not 
established by such approaches. TDP-43 is likely to perform one or more cytoplasmic 
roles including contribution to neuronal recovery as illustrated by the rapid, transient 
cytoplasmic translocation of TDP-43 in response to stress (Moisse et al., 2009; Sato et 
al., 2009). These observations led to the hypothesis that prominent cytosolic localization 
in neurons of ALS patients may actually represent the typical response to stress rather 
than an initiating event in pathogenesis (Moisse et al., 2009; Sato et al., 2009). This 
could provide a partial explanation for the remarkably common incidence of cytoplasmic 
TDP-43 accumulation in a variety of neurodegenerative conditions of seemingly 
different origins. Increased cytoplasmic localization of TDP-43 is associated with the 
formation of intracellular aggregates in the affected areas in patients (Neumann et al., 
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2006; Arai et al., 2006; Giordana et al., 2009) and in animal models including rats 
(Tatom et al., 2009), mice (Wils et al., 2010) and Drosophila (Li et al., 2010). In cell 
culture systems, increased cytoplasmic localization of TDP-43 was proposed to facilitate 
the formation of intracellular aggregates (Barmada et al., 2010; Winton et al., 2008; 
Nonaka et al., 2009). As in most neurodegenerative diseases where cytoplasmic 
aggregations are evident, an unresolved controversy is whether inclusions are 
neurotoxic or neuroprotective (Caughey et al., 2003), the latter presumably through the 
sequestration of smaller toxic species of misfolded proteins. The role of phosphorylation 
of TDP-43 in ALS patients has been explored with the help of phospho-specific 
antibodies that strongly bind to nuclear and cytoplasmic TDP-43. Using these, it has 
been identified as the major sites of phosphorylation on TDP-43 (Hasegawa et al., 
2008) and was found highly phosphorylated in the proposed pathologic 25 kDa CTFs 
(Inukai et al., 2008; Hasegawa et al., 2008). Although a correlation between insolubility 
and phosphorylation of TDP-43 has been reported (Igaz et al., 2009), phosphorylation is 
not required for C-terminal cleavage, aggregation or toxicity, at least in cellular models 
(Zhang et al., 2009; Dormann et al., 2009). Fragments (20?25 kDa) containing the 
carboxy-proximal portion of TDP-43 accumulate in detergent (sarkosyl)-insoluble 
fractions derived from patient CNS tissues (Neumann et al., 2006; Arai et al., 2006). 
These CTFs originate, at least in part, from proteolytic cleavage at Arg208 (Igaz et al., 
2009) and are more prominent in brains of ALS patients, whereas in the spinal cord of 
both groups, the predominant species within the inclusions are full-length TDP-43 (Igaz 
et al., 2008). When expressed in cells, the 25 kDa CTFs recapitulate some of the 
pathological features such as increased cytoplasmic accumulation, insolubility, 
hyperphosphorylation, polyubiquitination and cytotoxicity (Igaz et al., 2008; Zhang et al., 
2009; Caccamo et al., 2009). 
In transgenic mice expressing wild-type or mutant TDP-43, the appearance of the 25 
kDa CTF (Wils et al., 2010; Wegorzewska et al., 2009) was shown to increase with 
disease progression, arguing for a pathogenic role (Wils et al., 2010). Curiously, in 
contrast to observations in patients (Neumann et al., 2006; Arai et al., 2006; Igaz et al., 
2008) and in cell culture (Nishimoto et al., 2010; Zhang et al., 2009; Dormann et al., 
2009; Zhang et al., 2007), where 25 kDa CTF is mainly cytoplasmic, the same fragment 
in transgenic mice was present solely in the nucleus where it formed intranuclear 
inclusions (Wils et al., 2010). Caspase-3, which is activated during apoptosis, has been 
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proposed to be the main protease generating the 25 kDa CTF in cells (Nishimoto et al., 
2010; Zhang et al., 2009; Dormann et al., 2009; Zhang et al., 2007). The role of 
ubiquitination of TDP-43 in disease pathogenesis remains unknown, although it is likely 
to be a late event, since in patients the pre-inclusions and most TDP-43 inclusions are 
either weakly or not at all ubiquitinated (Giordana et al., 2009; Strong et al., 2007; Mori 
et al., 2008). Nevertheless, extensive ubiquitination of the pathologic CTFs in cells (Igaz 
et al., 2009) suggests that cellular degradation machineries such as the ubiquitin-
proteasome system (UPS) and/or autophagy (reviewed in Levine et al., 2008) may be 
involved in removing TDP-43 aggregates. 
 
6. Mechanisms in the pathogenesis of ALS 
Current understanding of the neurodegenerative process in ALS suggests that there 
may be a complex interplay between multiple mechanisms including not only 
environmental and genetic factors but also oxidative stress, excitotoxicity, protein 
aggregation, and damage to critical cellular processes, including axonal transport and 




Fig. 9. Mechanisms in the pathogenesis of ALS. ALS occurs as both a sporadic disease and a familial 
disease that, in part because of the heterogeneity of onset and progression, are clinically 
indistinguishable. There is increasing evidence that cellular functions that are impaired as a consequence 
of the expression of mutant genes in fALS converge on pathways that can be activated in sALS by other 
???????????????? ?????? ?????rs. Common pathways are represented by: (i) oxidative stress, which arises 
because of an imbalance between the production of ROS and the natural detoxifying defence and which 
might cause protein aggregation; (ii) mitochondrial dysfunction, which leads to oxidative stress, 
decreased activity of respiratory complexes, decreased ATP levels and cytochrome c release; (iii) 
excitotoxicity (the overstimulation of neurons by excitatory amino acid neurotransmitters such as 
glutamate), which causes the overloading of calcium ions into cellular compartments; (iv) defects in both 
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anterograde and retrograde axonal transport that impair axon?nuclear?axon communication; (v) deficit in 
neurotrophic growth factors, including brain-derived neurotrophic factor, ciliary neurotrophic factor, GDNF, 
IGF and VEGF; and (vi) neuroinflammation, which is a self-defence reaction that is aimed at neutralizing 
injurious stimuli that can become a harmful process. These pathways are activated in a complex 
neurotoxic cascade that involves molecular crosstalk between motor neurons and glia and between motor 
neurons and muscle, and leads to the non-cell-autonomous death of motor neurons. Therefore, 
??????????????????????????????????????????????????????????????????????????????????????????????????r increasing 
the lifespan or improving the quality of life of patients, or both. It is interesting that overlapping 
mechanisms are thought to function in several other neurodegenerative disorders such as spinal cord 
?????????????? ?????????????????????????????????????????????????????????? (Carrì et al., 2006). 
 
Recently there has been growing interest in the role played by non-neuronal 
neighbourhood cells in the pathogenesis of motor neuron injury and in dysfunction of 




Fig. 10. Non?cell autonomous toxicity of mutant SOD1 produced by a combination of damage to different 
cell types. Mutant SOD1 caused intrinsic damage to motor neurons. The reduction of mutant SOD1 in 
motor neurons delays the onset of disease and extends the lifespan of transgenic ALS mice. Reduction of 
mutant SOD1 in microglia affects disease duration after onset, suggesting a role for microglia in the 
propagation of the disease. Although there is cell-autonomous damage caused by mutant SOD1 in the 
motor neurons, this may not be sufficient to trigger and propagate ALS pathogenesis (Julien 2007). 
 
The relative importance of these different pathways may well vary in different subgroups 
of patients, and a very important task for clinicians and scientists in the future is to 
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further delineate the subcategories of motor neuronal diseases. Evidence has also 
accumulated that the final process of motor neuron death is likely to occur through a 
caspase dependent programmed cell death pathway resembling apoptosis (Shaw et al., 
2005). 
 
6.1 Oxidative stress 
Oxidative stress causes structural damage and changes in redox-sensitive signaling. It 
arises from an imbalance between the generation and removal of reactive oxygen 
species (ROS), and/or from a reduction in the ability of the biological system to remove 
or repair ROS-induced damage (Ferraiuolo et al., 2011). The effects of oxidative stress 
within non-dividing cells such as neurons may be cumulative, and cellular injury by free 
radical species is a major potential cause of the age related deterioration in neuronal 
function that occurs in neurodegenerative diseases. There has been particular interest 
in the role of oxidative stress in ALS, given that mutations in SOD1, which encodes a 
key cellular antioxidant defence protein, underlie around 20% of familial ALS cases. The 
close clinical and pathological similarity between sporadic and SOD1 related familial 
subtypes of motor neuronal diseases suggest that common pathophysiological 
mechanisms may be operating. In relation to the toxic gain of function of the mutant 
SOD1 protein, oxidative damage or metal mishandling, or both, have been strongly 
implicated. The main hypotheses have been that mutations alter the structure of the 
SOD1 protein, allowing greater access of abnormal substrates to the active copper site 
of the dimeric enzyme, resulting in the production of damaging free radical species 
including peroxynitrite and hydroxyl radicals. Both peroxynitrite and hydroxyl radicals 
are highly reactive and can cause oxidative damage to proteins, lipids and DNA. Such 
damage can alter protein conformations and disrupt enzyme active sites, change the 
properties of cellular membranes by oxidation of unsaturated fatty acids, and introduce 
mutations into DNA (Fig. 11) (Sian et al., 2006). 
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Nitration of tyrosine residues on cellular proteins by peroxynitrite can have damaging 
consequences (Beckman et al., 1993). Some mutations in SOD1 render the protein 
more likely to form a zinc deficient variant (Crow et al., 1997; Estevez et al., 1999), 
which in turn makes the copper site more accessible to abnormal substrates. In vitro 
studies have shown that zinc deficient SOD1 causes peroxynitrite dependent cell death. 
Recently developed cellular models of mutant TAR DNA-binding protein 43 (TDP-43)-
related ALS indicate that the presence of this mutant protein also induces oxidative 
stress in motor neuronal cell lines (Duan et al., 2010). 
 
6.2 Excitotoxicity 
Glutamate is the main excitatory neurotransmitter in the CNS and exerts its effects 
through an array of ionotropic and metabotropic postsynaptic receptors. The excitatory 
signal is terminated by removal of glutamate from the synaptic cleft by glutamate 
reuptake transporters, the most abundant of which is excitatory amino acid transporter 2 
(EAAT2; also known as SLC1A2 or GLT1). Excitotoxicity is the term coined for neuronal 
injury induced by excessive stimulation of glutamate receptors, by mechanisms which 
include derangement of intracellular calcium homeostasis and excessive free radical 
production (Fig. 12). Motor neurons are particularly susceptible to toxicity through 
activation of cell surface AMPA receptors (Carriedo et al., 1996). A body of evidence, 
which is still circumstantial, has implicated glutamatergic toxicity as a contributory factor 
to motor neuron injury. The key findings are that the expression and function of the 
major glial glutamate reuptake transporter protein EAAT2 may be impaired in the CNS 
of ALS patients and that CSF (and therefore CNS extracellular fluid) levels of glutamate 
appear to be abnormally raised at least in a proportion of ALS patients (Rothstein et al., 
1995; Fray et al., 1998; Shaw et al., 1995; Spreux-Varoquaux et al., 2002).  
Fig. 11. Sources of reactive oxygen species and 
their targets. ROS are produced during oxidative 
phosphorylation in mitochondria, by oxidative 
enzymes including cytochrome P450 in the 
endoplasmic reticulum, and by xanthine oxidase 
(XO) and reduced metal ions in the cytosol. Cellular 
targets attacked by ROS include DNA, proteins, 
membrane lipids, and mitochondria (Barber et al., 
2006). 
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The balance of evidence does not favour RNA mis-splicing as the cause of reduced 
EAAT2 expression as discussed above. Excitotoxicity has provided one of the few 
examples of a mechanistic link between mutant SOD1 mediated the sporadic form of 
the disease. The presence of mutant SOD1 increases the sensitivity of motor neurons 
to glutamate toxicity (Roy et al., 1998; Kruman et al., 1999), causes alteration in AMPA 
receptor subunit expression (Spalloni et al., 2003), and causes reduced expression of 
the major glutamate reuptake transporter EAAT2 (Bendotti et al., 2001). Whether as a 
primary or a propagating process, it appears that glutamate toxicity plays a contributory 
role to the injury of motor neurons in ALS.  
 
6.3 Mitochondrial dysfunction 
Mitochondria have a central role in intracellular energy production, calcium homeostasis 
and control of apoptosis. Several lines of evidence implicate mitochondrial dysfunction 
in ALS pathogenesis (Fig. 13). 
Fig. 12. Oxidative stress potentially influences other 
proposed mechanisms of neurodegeneration in ALS. 
Excitotoxicity leads to increased intracellular calcium 
levels that are buffered by mitochondria leading to 
increased ROS production. ROS, in turn, inhibit 
glutamate uptake through the EAAT2 transporter in 
glial cells. ROS can also cross the cell membrane 
and activate microglia, which respond by releasing 
cytokines and further ROS. Aberrant oxidative 
reactions catalysed by mutant SOD1 increase 
production of the highly reactive peroxynitrite and 
hydroxyl radical, causing nitration and aggregation of 
proteins including mutant SOD1 itself, and may also 
inhibit neurofilament assembly and cytoskeletal 
transport. Zinc binding to neurofilaments could 
deplete zinc binding to mutant SOD1 and exacerbate 
aberrant SOD1 chemistry (Barber et al., 2006). 
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Fig. 13. Mitochondrial dysfunction in ALS. a) Studies on postmortem tissue and animal models of ALS 
have indicated a decrease in the activity of the complexes that form the mitochondrial electron transport 
chain, which may be caused by oligomers of mSOD1 associating with mitochondria. These oligomers 
could to lead to alterations in the mitochondrial redox state, damage to the mitochondrial protein import 
machinery, and sequestration of the antiapoptotic factor Bcl-2. Loss of EAAT2, and increased expression 
of calcium-permeable AMPA receptors lacking the edited form of the GluR2 subunit, leads to elevated 
intracellular calcium in motor neurons. High intracellular calcium concentrations may result in a toxic shift 
of calcium from the endoplasmic reticulum to the mitochondria, leading to excitotoxicity. Defective 
electron transport chain activity and calcium homeostasis are thought to underlie aberrant ROS 
generation. b) Together, these pathways result in depolarization of the mitochondrial membrane potential, 
reduced production of ATP, increased peroxidation of mitochondrial membrane lipids, opening of the 
MPTP channel, and initiation of apoptosis with release of cytochrome c into the cytoplasmic 
compartment. Abbreviations: ALS, amyotrophic lateral sclerosis; AMPA, ?-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid; EAAT2, excitatory amino acid transporter 2; MPTP, mitochondrial permeability 
transition pore; mSOD1, mutated superoxide dismutase 1; ROS, reactive oxygen species (Ferraiuolo et 
al., 2011) 
 
Age related deterioration in mitochondrial function is considered a potentially important 
factor contributing to late onset neurodegenerative diseases. It is reviewed the existing 
evidence linking the expression of mutSOD1 to the many facets of mitochondrial 
dysfunction in ALS; recent studies suggests that the association and misfolding of the 
mutant protein (and possibly of the wild type protein as well) within these organelles is 
causally linked to their functional and structural alterations (Carrì and Cozzolino, 2001). 
The key evidence for mitochondrial dysfunction in human ALS includes the following: 
- alteration in the morphology of mitochondria in hepatocytes, muscle and motor 
neurons; 
- increased mitochondrial volume and calcium levels within motor axon terminals in 
muscle biopsies from sporadic ALS cases (Siklos et al., 1996); 
- reduced complex IV activity in spinal motor neurons in sporadic ALS (Borthwick et al., 
1999); 
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- high frequency of mitochondrial DNA mutations in motor cortex tissue in sporadic ALS 
(Dhaliwal et al., 2000); 
- multiple mutations and decreased mitochondrial DNA in muscle and spinal cord in 
sporadic ALS (Wiedemann et al., 2002); 
- ALS-like phenotype in one patient with a deletion in the cytochrome oxidase c 
subunit/gene (Comi et al., 1998). 
Energy deficit, calcium mishandling and oxidative stress are paralleled by alteration in 
mitochondrial motility, dynamics and turnover and most probably lead to mitochondria-
dependent cell death (Carrì and Cozzolino, 2011). Further evidence for the role of 
mitochondrial dysfunction as a contributory factor to motor neuron injury has come from 
the examination of cellular models of SOD1 related ALS. It has been demonstrated that 
mutant SOD1 proteins associated with the mitochondria tend to form cross-linked 
oligomers and that their presence causes a shift in the redox state of these organelles 
and results in impairment of respiratory complexes, this behaviour may explain the 
toxicity of ALS-mutant SOD1 proteins, which causes motor neurons to die (Ferri et al., 
2006; Ferri et al., 2010). Expression of mutant (G93A) SOD1 in the NSC34 motor 
neuron cell line results in the development of morphologically swollen mitochondria, 
impaired activity of complexes II and IV of the mitochondrial respiratory chain, impaired 
cellular bioenergetic status, and alteration in the mitochondrial proteome (Takeuchi et 
al., 2002). Mitochondrial dysfunction has also been studied in mutant SOD1 transgenic 
mice. At least in some strains (for example, G93A) mitochondrial vacuolation within 
motor neurons is an early feature of the pathology (Wong et al., 1995). Whereas SOD1 
was previously considered to be an exclusively cytosolic protein, it is now recognised 
also to reside in the intermembrane space of mitochondria (Higgins et al., 2002). SOD1 
has been shown to accumulate in vacuolated mitochondria in mutant SOD1 mice 
(Jaarsma et al, 2001). It has been shown that the activities of several complexes of the 
mitochondrial respiratory chain are reduced before disease onset and that these 
changes increase with age. Neurodegeneration in motor neuron disease at the onset of 
the murine disease (Mattiazzi et al., 2002). Several groups have shown translocation of 
cytochrome C, an initiator of apoptosis, from the mitochondria to the cytosol during 
disease progression in the mouse (Guegan et al., 2001; Zhu et al., 2002). Partial 
deficiency of the mitochondrial form of SOD (MnSOD) exacerbates disease in 
transgenic SOD1 mice (Andreassen et al., 2000). Recently it has been reported that 
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mutant SOD1 is selectively and aberrantly recruited to the cytoplasmic face of 
mitochondria in spinal cord tissue from mutant SOD1 transgenic mice. Covalently 
damaged adducts of mutant SOD accumulated on the cytoplasmic face of mitochondria 
in the spinal cord (Liu et al., 2004). This tissue specific recruitment raises the possibility 
that mitochondrial abnormalities may be involved in the initiation of motor neuron injury. 
Recently it has been showed that the antiapoptotic protein Bcl2 may be entrapped 
within large protein aggregates of SOD1 in spinal cord tissue, which may result in 
reduction of the availability of this protein to regulate apoptosis (Pasinelli et al., 2004; 
Pedrini et al., 2010).  
 
6.4 Cytoskeletal elements and axonal transport  
Neurofilament proteins form a major component of the cytoskeleton of neurons, and 
important functions include maintenance of cell shape and axonal calibre, as well as 
axonal transport. Neurofilaments are the most abundant structural proteins in large cells 
with long axons such as motor neurons. Neurofilament subunits are assembled in the 
motor neuron cell body, and transported down the axon by slow axonal transport, with 
progressive phosphorylation during movement down the axon. Neurofilament subunits, 
classified according to their molecular weight as light (NF-L), medium (NF-M) or heavy 
(NF-H), have been identified as targets for oxidation by ROS produced by mutant 
SOD1. Accumulation and abnormal assembly of neurofilaments are common 
pathological hallmarks of ALS. Ubiquitinated inclusions with compact or Lewy bodylike 
morphology within surviving motor neurons in ALS may show immunoreactivity for 
neurofilament epitopes. The importance of neurofilaments in the normal functioning of 
motor neurons is demonstrated by the finding that approximately 1% of sporadic ALS 
cases have deletions of insertions in the KSP repeat region of the neurofilament heavy 
(NF-H) gene (Figlewicz et al., 1994; Tomkins et al., 1998). In addition, pathological 
changes within motor neurons develop in mice overexpressing NF-light or NF-heavy 
subunits, or in mice expressing mutations in the NF-light gene (Xu et al., 1993; Lee et 
al., 1994). Genetic manipulations to alter the expression of neurofilament proteins have 
been shown to alter the disease course in SOD1 transgenic mice. Increased expression 
of NF-heavy, which traps most neurofilaments within the cell body, robustly improves 
the disease course, by as much as six months in mutant SOD1 mice (Couillard-
????????? ??? ????? ??????? ???? ???????? ???? ????? ????????? ???????????????? effect are not 
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understood, though it has been suggested that excess neurofilaments within the cell 
body may function as a buffer for some other deleterious process, for example offering 
phosphorylation sites for dysregulated intracellular kinases, or reducing the burden of 
axonal transport (Lariviere et al., 2003). Motor neurons, which in the human nervous 
system may have axons up to one metre in length, are highly reliant on an efficient 
intracellular transport system with anterograde and retrograde components. It is 
interesting that in SOD1 mutant mice, axonal transport is demonstrably impaired several 
months before clinical disease onset (Williamson et al., 1992). The kinesin complex of 
proteins are important molecular motors for anterograde axonal transport on the 
microtubule system. Mutations of genes encoding several kinesin proteins have been 
shown to cause various types of motor neuron. The dynein?dynactin complex is the 
important motor for retrograde transport on the microtubule system, returning 
components (for example, multivesicular bodies and neurotrophic factors) back to the 
cell body. Mutations in dynein and the dynactin complex, which is an activator of 
cytoplasmic dynein, cause progressive motor neuron disease in mice (LaMonteet al., 
2002; Hafezparast et al., 2003). As discussed in the genetics section, a dominant point 
mutation is the P150 subunit of dynactin, which causes a lower motor neuron disorder 
with vocal cord paresis in human subjects (Puls et al., 2003). 
 
6.5 Inflammatory cascades and the role of non-neuronal cells 
Recently there has been increasing interest in the possibility that non-neuronal cells, 
including activated microglia and astrocytes, may contribute to the pathogenesis or 
propagation of the disease process in ALS. Several studies in genetically engineered 
mouse models have indicated that expression of mutant SOD1 in neurons alone is 
insufficient to cause motor neuron degeneration and that participation of non-neuronal 
cells may be required (Pramatarova et al., 2001; Lino et al., 2002; Ferri et al., 2004). 
More recently Clement and colleagues produced several sets of chimeric mice which 
have both normal and mutant SOD1 expressing cells (Clement et al., 2003). Motor 
neurons expressing mutant SOD1 could escape disease if surrounded by a sufficient 
number of normal non-neuronal cells. Conversely normal motor neurons surrounded by 
mutant SOD1 containing non-neuronal cells developed signs of abnormality, with the 
development of ubiquitinated intraneuronal deposits. Astrocytes have many functions 
relevant to motor neuron physiology. First, they express the most important glutamate 
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transporter EAAT2/GLT-1, thus contributing to the clearance of this neurotransmitter; 
deficiency of astroglial EAAT2/GLT-1 causes severe motor neuron loss (Foran and 
Trotti, 2009) and alteration of this transporter has been repeatedly invoked as a cause 
contributing to ALS (Rothstein, 2009). Second, astrocytes are the major source of both 
trophic (Ekestern, 2004) and toxic factors (Ferri, 2004) for motor neurons. Several 
cytokines have been proposed to play a role in ALS as reinforcing signals from glia 
cells, including interleukin-?? ??????? ??????? ????????? ??????? ?? ???????? ?????????
chemoattractant protein-1, monocyte colony-stimulating factor (MCSF) and transforming 
??????????????????????????????????????????????????????????????????????????????????????
epidermis from ALS patients, although with sometimes conflicting results (Papadimitriou 
et al., 2010). In addition, the production of nitric oxide and the activation of 
cyclooxygenase type 2 (COX2) aggravate the toxic effects of mutant SOD1 in several 
experimental models for ALS. The production of all those proinflammatory mediators 
may be secondary to the induction of the transcription factor NF-?????????????????vated 
in the presence of reactive oxygen species (ROS) and by many other different signalling 
molecules associated with ALS onset and progression (Migheli et al., 1997; Kaltschmidt 
et al., 2005). NF-?????????????????????????????????????????????????????????tients and 
in human cells expressing mutant SOD1 (Casciati, et al., 2002). NF-??????????????????
the expression of COX2 that may cause an increase in the synthesis of prostaglandins, 
which trigger astrocytic glutamate release and induce free radical formation, thus 
contributing to both excitotoxicity and oxidative damage. Indeed, treatment with COX2 
inhibitors markedly protects motor neurones and significantly prolongs survival of ALS 
mice (Pramatarova et al., 2001). Surpriseling NF-?????????????????? ???????ocytes, via 
espression of the dominant negative I?B-alpha-AA, fails to influence onset, severity, or 
progression of disease in a mutant SOD1-based ALS mice model (Crosio et al., 2006). 
Recently it has been shown that also microglia play a critical role as resident 
immunocompetent and phagocytic cells within the CNS. Activation is associated with 
transformation to phagocytic cells capable of releasing potentially cytotoxic molecules 
including reactive oxygen species, nitric oxide, proteases, and proinflammatory 
cytokines such as interleukin-1B, tumour necrosis factor a (TNF?), and interleukin 6 (IL-
6) (Gonzales-scarano et al., 1999). Given this, there is little doubt that activated 
microglia can inflict significant damage on neurons, but their role is complex and they 
are capable of stimulating neuroprotective as well as neurotoxic effects. Proliferation of 
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activated microglia is a prominent histological feature in the spinal ventral horn both in 
mutant SOD1 transgenic mice and in human ALS (Alexianu et al., 2001; Kauamata et 
al., 1992). In the mice, microglial activation is present before the onset of significant 
motor neuron loss or motor weakness. Various inflammatory cytokines or enzymes are 
upregulated in the spinal cord of ALS patients (IL-6, IL-1?, cyclo-oxygenase 2 (COX2), 
and prostaglandin E2 (PGE2)) or, in the spinal cord of mutant SOD1 mice (IL-1?, TNF?, 
COX2, PGE2) (Sekizawa et al., 1998; Hensley et al., 2002). Microglia appear to 
mediate the toxicity to neurons in patients with ALS by releasing factors that enhance 
glutamate toxicity (Brooks et al., 1995). It would be very relevant to identify molecules 
that contribute to this propagation and those released from activated microglia would 
???????? ??? ?????????? ???????????? ??? ?? ??????? ?????? ?? ?brosi and collegues have 
investigated about how mutant SOD1 affects P2 receptor-mediated proinflammatory 
microglial activation, considering that extracellular ATP is one of the most widespread 
microglia alarm signal endogenous to the CNS, and that ATP signaling evokes many 
proinflammatory functions of microglia. They observed up-regulation of P2X(4), P2X(7), 
and P2Y(6) receptors and down-regulation of ATP-hydrolyzing activities in mutant 
SOD1 microglia. This potentiation of the purinergic machinery reflected into enhanced 
sensitivity mainly to 2'-3'-O-(benzoyl-benzoyl) ATP, a P2X(7) receptor preferential 
agonist, and translated into deeper morphological changes, enhancement of TNF-? and 
cyclooxygenase-2 content, and finally into toxic effects exerted on neuronal cell lines by 
???????????????????????????????????? ???????????????????????????????????????????????????
microglia may thus constitute a new route involved in the progression of ALS to be 
exploited to potentially halt the disease.  
 
6.6 Protein aggregation  
A recurring theme highlighted in research into neurodegenerative diseases has been 
the misfolding of mutant proteins with the formation of intracellular aggregates. Protein 
aggregates are found in motoneurons in models for ALS linked to a mutation in the 
gene coding for SOD1 and in ALS patients as well. Several hypotheses have been put 
forward to explain how mutant SOD1 aggregates could produce cellular toxicity. First, 
there might be sequestration of other proteins required for normal motor neuron 
function. Several additional proteins have been found present in SOD1 aggregates 
including CCS (copper chaperone for SOD1), ubiquitin neurofilaments, glial fibrillary 
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acidic protein, two neuronal glutamate transporters, Bcl2, and proteins involved in 
chaperone and proteosome functions (Pasinelli et al., 2004; Watanabe et al., 2001). 
Second, by repeatedly misfolding, the SOD1 aggregates may reduce the availability of 
chaperone proteins required for the folding and function of other essential intracellular 
proteins (Bruening et al., 2002). Third, the SOD1 mutant protein aggregates may reduce 
proteasome activity needed for normal protein turnover (Allen et al., 2003; Jhonston et 
al., 2000). Fourth, there could be inhibition of the function of specific organelles (for 
example, mitochondria) by aggregation on or within these organelles. Over-expression 
of chaperone proteins can reduce mutant SOD1 aggregation and enhances the survival 
and function of motor neurons in culture (Takeuchi et al., 2002). Aggregation of mutant 
SOD1 in the cytoplasm and/or into mitochondria has been repeatedly proposed as a 
main culprit for the degeneration of motor neurons. It is, however, still debated whether 
SOD1 aggregates represent a cause, a correlate or a consequence of processes 
leading to cell death. It has been demonstrated in a recent study that the over-
expression of Grx1 increases the solubility of mutant SOD1 in the cytosol but does not 
inhibit mitochondrial damage and apoptosis induced by mutant SOD1 in neuronal cells 
(SH-SY5Y) or in immortalized motor neurons (NSC-34). Conversely, the over-
expression of Grx2 increases the solubility of mutant SOD1 in mitochondria, interferes 
with mitochondrial fragmentation by modifying the expression pattern of proteins 
involved in mitochondrial dynamics, preserves mitochondrial function and strongly 
protects neuronal cells from apoptosis (Ferri et al., 2010).  
The identification of TDP-43 as the major protein constituent of these inclusions initiated 
a major shift in our understanding of the patho-biology of ALS. As I have said before, 
under normal conditions, TDP-43 is predominantly localized in the nucleus, and loss of 
nuclear TDP-43 staining is seen in most cells containing TDP-43-positive cytoplasmic 
inclusions (Neumann et al., 2006). TDP-43 inclusions are not restricted to motor 
neurons, and it seems that cytoplasmic redistribution of TDP-43 is an early pathogenic 
event in ALS (Giordana et al., 2010). Similarly, cytoplasmic inclusions containing mutant 
fused in sarcoma (FUS) protein have been observed in some patients with FUS-related 
FALS (Groen et al., 2010; Hewitt et al, 2010).  
Proteins found in aggregates in ALS provide several important clues about the disease 
pathogenesis. Loss of nuclear TDP-43 and/or aggregation of the protein in cytoplasmic 
inclusions may be key pathogenic processes in both SALS and FALS. 
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6.7 DNA/RNA metabolism  
Identification of TDP-43, a ubiquitously expressed RNA?DNA binding protein, as a 
major component of the ubiquitinated inclusions in ALS focused attention on altered 
RNA processing as an important potential pathophysiological mechanism in this disease 
(Fig. 14).  
 
Fig. 14. Schematic diagram of the mRNA metabolism pathway from transcription through to degradation. 
Pre-mRNA is generated from DNA by RNA polymerase II and then processed by the spliceosome into 
mRNA. mRNA is incorporated into an RNP complex which is then shuttled to the cytosolic compartment 
where it is further modified into either transport granules, translationally quiescent stress granules or 
processing bodies in which mRNA is targeted to degradation. There is significant interchange of mRNAs, 
however, between each of these compartments, with each having the capacity to return the mRNA to a 
translationally active polysome. mRNA degradation is modulated, in part, by the incorporation of miRNA 
into the mRNP complex. Complete complementarity with the target mRNA will lead to mRNA degradation, 
while incomplete complementarity will lead to translational inactivation but not necessarily degradation. 
Sites at which both TDP-43 and FUS can impact on RNA metabolism are shown as red arrows, while 
those at which only TDP-43 has been identified to interact are shown as blue arrows. Note the many 
steps at which FUS/????????????????-43 may have an effect on the pathway, each of which may manifest 
as overall changes in the cellular phenotype (Strong and Volkening, 2011). 
 
The mRNA is first produced as a pre-mRNA from which non-coding sequences (introns) 
are removed by the spliceosome, a large RNP complex in which both TDP-43 and 
FUS/TLS can be found (Freibaum et al., 2010; Sephton, et al. 2011). Once spliced, 
mature mRNA is transported from the nucleus (Iko et al., 2004). With the inclusion of 
molecular motors including dynein (retrograde transport) or kinesin (anterograde 
transport), the resulting transport granules shuttle mRNA to the location at which it is 
required for translation. Under conditions of cellular stress, transport granules and 
translation initiation complexes may be quickly converted into translationally quiescent 
granules known as stress granules (SGs). Typically, SGs are believed to store mRNA 
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that is required in response to cellular stress or injury until such time as the mRNA is 
required to be translationally competent, or they may serve as locations to repair 
abnormal translational complexes that are inoperative (Buchan et al., 2009). Regardless 
of purpose, mRNA sequestered to SGs is translationally quiescent. Interestingly, dynein 
and kinesin appear to play opposing roles in SG dynamics, with knock-down of dynein 
impairing SG formation while kinesin is required for SG dissolution (Loschi et al., 2009). 
SGs exist in a dynamic equilibrium with processing bodies (P-bodies), cytoplasmic RNA 
granules that mediate RNA degradation through a mechanism involving decapping 
followed by XRN1 digestion of the mRNA (Parker et al., 2007; Sheth et al., 2003). 
These structures are also translationally inactive. In addition to this route of mRNA 
degradation, AU-rich mRNA and RNA that does not satisfy quality control mechanisms 
in the cell are commonly ?????????????????????????????????? manner (Mukherjee et al.. 
2002; Houseley et al., 2006; Chen et al., 2001). Targeting of mRNA for silencing or 
degradation is also controlled by the incorporation of microRNA (miRNA) into mRNA 
containing granules. miRNA is transcribed from DNA as pri-miRNA, processed by 
DGCR8/Drosha, exported as pre-miRNA and further processed by Dicer/TRB in 
association with Argonaut proteins (Macfarlane and Murphy 2010; Fiesel and Kahle, 
2011). It is then incorporated into the RNA-induced silencing complex (RISC) where 
removal of the complementary strand yields the mature miRNA that is incorporated into 
the mRNA-containing granule (Gregory et al., 2004; Liu et al., 2008; Pillai 2005; Jabri 
2005). Complete complementarity results in rapid degradation of the mRNA while 
incomplete complementarity translationally silences the mRNA (Nelson et al., 2008). 
However, it must be noted that this is not an absolute as some miRNA may cause an 
increase in translation (Orom et al., 2008). From the description of the RNA metabolism 
pathway above, it is clear that a very important part of this process is the dynamic 
nature in which regulatory factors such as miRNA and proteins interact with the mRNA 
throughout this process and the effects this can have on RNA stability, 
compartmentalization (Chaudhury et al 2010) and the ultimate fate of the mRNA (Singh 
and Valcarcel, 2005). This concept of dynamic plasticity of the RNP granule is 
unfortunately often put aside in the discussion of any single RNA binding protein and its 
relevance to ALS (Strong and Volkening, 2011). 
A further recent study indicates that mutant TDP-43 dysregulates alternative splicing of 
mRNA (Highley et al., 2010). Fibroblast cell lines derived from patients with TARDBP-
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related ALS showed the expected loss of nuclear expression of TDP-43, together with 
widespread changes in RNA splicing, including changes in transcripts of other RNA-
processing genes and genes that have been previously implicated in ALS. The authors 
concluded that splicing dysregulation associated with loss of nuclear TDP-43 is likely to 
contribute to the pathophysiology of ALS. 
Further evidence of dysfunctional RNA metabolism in ALS emerges from the presence 
of mutations in angiogenin (ANG) (Greenway et al., 2006) and the DNA?RNA helicase 
senataxin (SETX) in some cases. ANG, the expression of which is increased during 
hypoxia to promote angiogenesis, also acts as a transfer RNA-specific ribonuclease and 
regulates ribosomal RNA transcription (Kieran et al., 2008). A proposed mechanism by 
which ANG normally prevents cell death is inhibition of the translocation of apoptosis-
inducing factor into the nucleus (Li et al., 2011). Mutations in ANG are likely to have a 
deleterious effect through loss of function, as over-expression of ANG extends the 
lifespan of mSOD1 mice (Kieran et al., 2008). SETX autosomal dominant mutations are 
associated with juvenile-onset FALS (Chen et al. 2004). The SETX protein is predicted 
to be a component of large ribonucleoprotein complexes, with roles in maintaining DNA 
repair in response to oxidative stress, and RNA processing (Chen et al. 2004). The 
mechanisms by which mutant SETX causes ALS remain to be determined.  
Additional evidence that dysregulated RNA processing may contribute to motor neuron 
injury in ALS arises from the detection of biomarkers of RNA oxidation in human ALS 
and mSOD1 mice (Chang et al., 2008), and the transcriptional repression within motor 
neurons that occurs in the presence of mSOD1 (Kirby et al., 2005; Ferraiuolo et al., 
2007). 
 
7. Motor neuron death in ALS: a role for apoptosis 
Cell death can occur by different possible mechanisms, including autophagy, necrosis 
and apoptosis. Autophagy seems to prevail as a protein clearing system over other 
multienzymatic pathways such as the proteasome within motor neurons. The evidence 
which links an altered autophagy to the onset of motor neuron death proposes that this 
biochemical pathway might represent a final common mechanism underlying both 
inherited and sporadic forms of ALS (Crippa et al., 2010; Nassif and Hetz, 2010; 
Pasquali et al., 2010). 
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Necrosis is the classically recognised form of cell death and is characterised by high 
amplitude swelling of the mitochondria, nuclear flocculation and uncontrolled cell lysis. 
Tissue necrosis is normally seen following severe trauma to cells. The alternative form 
of cell death is via a programmed sequence of events and is termed apoptosis.  
The pathways of apoptosis play an integral part in many biologic events, including 
morphogenesis, cell turnover, and the removal of harmful cells, and balanced apoptosis 
is crucial to ensuring good health. Cell death via apoptosis follows the activation of 
effector proteases called caspases, which participate in enzymic cascades that 
terminate in cellular disassembly (Los et al., 2001; Green et al., 1999). This action can 
occur through several routes, including mitochondria independent and -dependent 
pathways. Cells undergoing apoptosis commit suicide in an orderly fashion by cutting 
themselves into membrane-packaged parcels after cleavage of their chromosomal 
DNA, and then they are removed by phagocytic cells. Two major cells for clearing and 
degrading apoptotic bodies and necrotic material are dendritic cells (DCs) and 
macrophages. The highly orchestrated form of cell death and clearance is critical to the 
health of many organisms during development, and also for maintaining the normal 
function of the immune system. The importance of regulation of cell numbers and/or the 
removal of aged, damaged, or autoimmune cells to minimize inflammatory or immune 
reactions is discussed (Fields et al., 2001). There are two pathways of activation: 
intrinsic and extrinsic pathway. In the extrinsic one, the activation of apoptotic pathways 
and programmed cell death are initiated by the binding of a specific protein ligand to a 




Fig. 15. The 2 major pathways of 
apoptosis?the extrinsic (Fas and other 
TNFR superfamily members and ligands) 
and the intrinsic (mitochondria-associated) 
pathways. Both pathways lead to 
activation of caspase-3, giving rise to 
apoptotic cell death. Only a few examples 
of proteins that directly affect cell death 
and the resulting DNA fragmentation are 
shown in the simplified diagram. Most of 
the effector and control proteins are 
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Apoptotic signals are transmitted to target cells via the TNF superfamily of death 
receptors (DRs), the members characterized by a conserved extracellular cysteine-rich 
motif. Each DRs has an intracellular death domain (DD) that function as a protein-
protein binding module after recruiting various cytosolic signaling molecole that 
comprise the specific apoptotic pathways. The DD of the receptor then recruits so-called 
adaptor proteins that also have DDs. This protein, which has a DD at its C-terminus and 
a second protein-protein interaction domain, called a death-effector domain, at its N-
terminus. The death effector domain of the adaptor protein binds to the death-effector 
domain, or prodomain, of caspase-8, and a complex termed the death-inducing 
signaling complex (DISC) is formed which subsequently signals proteolysis and 
endonucleolytic cleavage. Activated caspase-8 then activates a series of downstream 
caspases, such as caspase-3, that result in cleavage of structural and regulatory 
intracellular proteins, DNA fragmentation and cell death. In the intrinsic pathway 
caspases are activated by perturbance of the mitochondria, and this may lead to the 
opening of the mitochondrial permeability transition pore complex with organelle 
swelling, and then rupture of the outer membrane. This results in release of the 
apoptosis-stimulating molecules cytochrome c and apoptosis-inducing factor (AIF). A 
second mechanism allows direct release of cytochrome c and the other factors without 
evidence that the permeability transition pore complex has been opened to the 
environment. Bcl-2, a protein inhibitor of programmed cell death, blocks both the 
permeability transition pore opening and the release of cytochrome c (Susin et al., 
1996). Released cytochrome c induces multimerization of apoptosis protease-activating 
factor (Apaf)-1 to activate procaspases-9 and -3, The Bcl-2 family of proteins, located in 
the outer mitochondrial membrane, is important in preventing and permitting apoptosis, 
and is instrumental in controlling the release of cytochrome c (Monaghan et al., 1992; 
de Jong et al., 1994). In fact, all mitochondrial activities in apoptosis can be blocked by 
overexpression of Bcl-2 or Bcl-XL but overexpression is an experimental phenomenon 
that may not occur under normal physiologic conditions. Cytochrome c is a required 
cofactor and forms a complex with Apaf-1, procaspase-9, and deoxyadenosine 
monophosphate (dATP) (Li et al., 1998). The large complex is called the apoptosome. 
Apaf-1 is an adaptor protein that binds procaspase-9 through the caspase activation 
and recruitment domain, resulting in caspase-9 auto-activation in the presence of 
cytochrome c and ATP or dATP. After caspases-9 and -8 are activated, cleavage and 
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activation of additional upstream caspases in amplifying loops may occur, or this action 
allows caspase-9 to activate downstream caspases such as caspase-3, leading to 
endonuclease-?????????????? ??? ???? ??????? ???? ????????? ??? ????? ????). The balance 
between pro- and anti-apoptotic proteins (Bcl-2 family members) expressed in the outer 
mitochondrial membrane probably determines whether programmed cell death is 
initiated or whether the cell will survive (Pellegrini et al., 1999; Antonsson et al., 2000). It 
was later determined that Bcl-2 family members interact with one another, forming 
heterodimers and, occasionally, homodimers. Members of this family either inhibit or 
promote cell death, and together with mitochondria, cytochrome c (a required co-factor 
for Apaf-1), AIF, intracellular balances of dATP or ATP, and caspases, are involved in 
the initiation and execution of the intrinsic pathway (Oltvai et al., 1993; Korsmeyer et al., 
1999). The relative concentration of family members acts as a gauge for cell death. This 
family comprises nearly 20 proteins divided into two main groups. Antiapoptotic 
members such as Bcl-2, Bcl-xL, Bcl-w, Bfl-1, and Mcl-1 promote cell survival, whereas 
proapoptotic members such as Bax and Bak function as death effectors (Schultz et al., 
2003). 
 
7.1 Evidences for apotosis during ALS progression 
Neuronal apoptosis has been suggested to underlie the neurodegeneration of motor 
neurones expressing mutant SOD1. In fact while wild-type SOD1 is anti-apoptotic in 
neuronal cultures and a determinant of lifespan in Drosophila (Rothstein et al., 1994; 
Rabizadeh et al., 1995; Greenlund et al., 1995; Parkes et al., 1998), mutant SOD1 
proteins are pro-apoptotic both in vitro and in vivo (Durham et al., 1997; Pasinelli et al., 
1998; Pasinelli et al., 2000). Thus, alteration in the expression of the pro- and anti-
apoptotic genes, activation of caspases and release of cytochrome-c have been found 
in the spinal cord of transgenic mice expressing SOD1 with the G93A mutation and in 
human ALS patients without SOD1 mutations (Vukosavic et al., 1999; Pasinelli et al., 
1998; Pasinelli et al., 2000; Guegan et al, 2003). In addition, survival of the SOD1G93A 
ALS mice is prolonged by overexpression of Bcl2 (Kostic et al., 1997), by inhibition of 
caspase-1 (Friedlander et al., 1997), and by treatment with the pancaspase inhibitor 
ZVAD-fmk (Li et al., 2000). Moreover we have demonstrated that overexpression of 
SOD1G93A requires the expression of Apaf1 to induce cell death (Cozzolino et al., 2004). 
Intriguingly it has been demonstrated that both WT and mutant SOD1 can bind Bcl2, 
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providing evidence of a direct link between SOD1 and an apoptotic pathway (Pasinelli, 
2004).  
Experimental evidences have demonstrated that, in ALS patients, motor neurons die for 
apoptosis. Crosio and collegues have investigated expression of the Bcl2 family 
members in spinal cords of transgenic SOD1G93A, SOD1WT and non-transgenic mice 
and it is resulted that Bcl2-A1 is the only member of this family to be upregulated in both 
asymptomatic and symptomatic G93A mice, with a tendency to decrease in the final 
stages of disease. Interestingly, this upregulation is tissue specific, as Bcl2-A1 mRNA is 
increased neither in the brain nor in the muscle of G93A transgenic mice. Moreover, 
induction of Bcl2-A1 in SOD1G93A transgenic mice occurs via NF-kB-independent 
pathway (Crosio et al., 2006). It has been shown that Bcl2-A1 has various effects in 
response to TNF-? in different cell cultures: it acts as an antiapoptotic in immune-
derived cell lines (Zong et al., 1999), in microvascular endothelial cells (Wang et al., 
1999) and in HT1080 fibrosarcoma cells (Karsan et al., 1996), whereas it is clearly pro-
apoptotic in B cells (Kucharczak et al., 2005). In different cell cultures (NSC-34, 
undifferentiated and differentiated ETNA cells and primary cultures from spinal cords), 
the overexpression of Bcl2-A1 and SOD1G93A increases the level of cell death after 
exposure to TNF-?, a situation mimicking the condition of neuroinflammation occurring 
in ALS (Crosio et al., 2006).  
For the important involvement of Bcl2-A1 in the motor neurons destiny, I have recently 
focused my attention on the gene Bcl2-A1.  
 
7.2. Bcl2-A1 
Bcl2-A1 (also known as Bcl2-related protein A1, BFL1; A1; Bfl-1/A1) was originally 
identified as a murine hematopoietic-specific, granulocyte-macrophage colony-
stimulating factor-inducible gene product (Choi et al., 1995; Karsan et al., 1996). The 
human Bcl2-A1 gene codes for a 175-amino acid Bcl2 family protein that has an anti-
apoptosis activity and is expressed abundantly in bone marrow and at a low level in 
several other tissues (Hung-Ha et al., 1998). Unlike other Bcl2 family proteins, 
expression of Bcl2-A1 permits limited cell proliferation over an extended period of time 
when cells are induced to undergo apoptosis (D'Sa-Eipper et al., 1998). Human Bcl2-A1 
can be considered as a homologue of mouse A1, because the two proteins share about 
72% amino acid identity (Choi et al., 1995; Karsan et al., 1996). Bcl2-A1 appears to be 
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induced by inflammatory cytokines, tumor necrosis factor and interleukin-1 (Karsan et 
al., 1996), and it has been shown to be a direct transcriptional target of NF-kB that is 
overexpressed in many human tumors and is a means by which NF-kappaB inhibits 
apoptosis (Zong et al., 1999; Wang et al, 1999; Simmons et al., 2008). Like Bcl2, Bcl2-
A1 can prolong cell survival in some experimental paradigms, e.g. it retards tumor 
necrosis factor-induced apoptosis in the human dermal microvascular cell line, HMEC-1 
(Karsan et al., 1996) and p53-induced apoptosis in the primary rat kidney cells (D'Sa-
Eipper et al., 1996). However, the function of Bcl2-A1 seems to be distinct from that of 
Bcl-2, because Bcl2-A1 permits cell proliferation (D'Sa-Eipper et al., 1996; D'Sa-Eipper, 
1998). It has also been demonstrated that Bcl2-A1 is the only known Bcl-2 family 
member to be induced by the inflammatory cytokines TNF? and IL-1? (Karsan et al., 
1996; Duriez et al., 2000). This unique characteristic of Bcl2-A1 prompted us to study 
the role of this protein in ALS, given all the above-mentioned links between 
neuroinflammation and disease progression. 
Recent studies have demonstrated that distinct subcellular localizations of this protein 
are correlated with its funtion. A previous research demonstrated that Bcl2-A1 does not 
contain a well-defined C-terminal transmembrane domain and deletion of the C-terminal 
24 amino acid region (corresponding to the transmembrane domain of other Bcl2 family 
proteins) partially reduces the various activities of Bcl2-A1 (?? ?-Eipper et al., 1998). 
Recent independent studies, with Bcl2-A1-overexpressing cells, suggested that Bcl2-A1 
localizes to the mitochondria (Werner et al., 2002; Kucharczak et al., 2005; Duriez et al., 
2000) and that the C-terminal end of Bcl2-A1 is important for anchoring Bcl2-A1 to the 
mitochondria (Duriez et al., 2000; Ko et al., 2003), moreover it has been found that C-
terminal region of Bcl2-A1 induces cell death that accompanies caspase activation 
when fused with GFP. (Yang et al., 2005). Brien and collegues have demonstrated that 
Bcl2-A1 may co-exist in two distinct conformational states, the first one with its C-
terminal helix 9 (residues 155?175) inserted in the hydrophobic groove formed by the 
BH1?3 domain of Bcl2-A1, and the second one with its C-terminal tail. Interestingly, 
thay have demonstrated that helical wheel projection of the C-terminal helix of Bcl2-A1 
highlights its amphipathic character, a feature of transmembrane helices or membrane 
anchors, and that both the anchorage of Bcl2-A1 to the mitochondria and the anti-
apoptotic function of the protein are dependent on the amphipathic nature of the C-
terminal helix. These data suggested that even though Bcl2-A1 may co-exist in two 
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distinct conformational states, most of the endogenous Bcl2-A1 seems to be tightly 
associated with the mitochondria via its C-terminal end and that the amphipathic nature 
of helix 9 is critical for that localization (Fig. 16, Brien et al, 2003). 
 
Fig. 16. Three-dimensional model of full length human Bfl-1. (a) Ribbon representations of Bfl-1 in its 
???????? ?????????? ?????? ?????????? ??? ???? ???????????????-binding cleft. (b) Bfl-1 in its extended form  
??????????????????????????????????????????????????-helices are colored sequentially from N- to C-terminal 
?????????????????????????????????-??????????????????????-???????????????????-??????????????????????-79); 
????????????????-??????????????????????-??????????????????????-????????????????8 (aa 139-???????????????
(aa 155-173). The 310 helix (aa 113-??????????????????????????????????????????????????????????????????
dark green (aa 149-154). Orientation of the model in figure (b) is deduced from that of left figure (a) by 
a90° clockwise rotation in the plane of the paper(Brien et la., 2009).  
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Material and Methods 
 
1. Material 
1.1 The bacterial strain  
Competent cells used are E. coli DH5 ?. Bacterial cells are defective for the restriction 
and have mutations in relA1 and recA1 genes, to improve the stability and quality of 
recombinant plasmids. 
 
1.2 Cell lines 
NSC34 cell line: Spinal Cord Neuronal Clone 34 (Durham et al., 1993). 
The NSC34 cell hybrids are obtained by fusion of neuroblastoma cells with mouse 
embryonic motor neuron cells. Even in the absence of specific agents exhibit 
characteristics of motor neuron differentiation and maintain the ability to proliferate 
actively in culture. 
SH-SY5Y cell line (Biedler et al., 1978): SH-SY5Y cells (ATCC number CRL-2266) are 
human cells derived from neuroblastoma cell line. 
HEK293 cell line: HEK293 are human embryonic kidney cells (Graham et al., 1977). 
 
1.3 Animals  
I used SOD1G93A transgenic mice (strain B6.Cg-Tg(SOD1?G93A)-1Gur from The 
Jackson Laboratory, 99.99% C57BL/6 genetic, 50% survive at 157.1±9.3 days, 
http://jaxmice.jax.org/strain/004435.html). Non-transgenic littermates were used as 
control.  
 
1.4 Plasmid constructions and oligonucleotides  
pGL2-promBcl2-A1WT: a fragment corresponding to mouse Bcl2-A1b gene promoter (ch 
NCBIM37:9:89093447:89103264:1), spanning from ? 2017 to + 129 was isolated by 
RT-PCR and was cloned in pGL2-Basic (Promega) (Adlam et al., 2003; Sung-Kyun et 
al., 2011). Oligonucleotides, used to amplify the promoter, had the XhoI recognition site 
(highlighted nt) used to digest pGL2-Basic vector: 
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pGL2-promBcl2-A1Nf-kB/AP1: Mutations of NF-?B and AP1 binding site (highlighted nt) 
were generated in the Bcl2-A1b promoter using the Quickchange site-directed 












GST-Bcl2-A1: a PCR fragment, corresponding to mouse Bcl2-A1b coding sequence 
(NM_007534.3), was cloned into BamHI and SmaI restriction sites of the pGEX-3 vector 
(GE healthcare) (Johnson et al., 1989; Fikrig et al., 1990). 
pCMV-mouse/human pro-caspase3: coding sequences corresponding to mouse 
(NM_009810) and human (NM_004346) pro-caspase 3 were isolated by RT-PCR and 
cloned into HindIII (for mouse pro-caspase3) or EcoRI (for human pro-caspase3) 
downstream to 3xFlag repeats (p3xFlag-CMV-10 vector, Sigma- Aldrich) (Andersson et 
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pCMV-SOD1WT/G93A: coding sequences corresponding to SOD1WT, SOD1G93A were 
isolated by RT-PCR from tissues of transgenic mice and cloning into Hind III and XbaI 
restriction sites of the pRc/CMV vector (Invitrogen) (Xing et al., 1996; Goldberg et al., 
1993). 
5xMyc-mouse Bcl2-A1b (Crosio et al., 2006; Ferri et al., 2006): coding sequence 
corresponding to mouse Bcl2-A1b (NM_007534.3) was obtained by cloning a PCR 
fragment corresponding to mouse Bcl2-A1b into StuI and XhoI restriction sites of pCS2-
MTK vector (Roth et al., 1991). 
mBcl2-A1b??1/??1-3/??7-9/??9: Bcl2-A1 deletion mutants were obtained by mutagenesis, 
using the Quickchange site-directed mutagenesis kit (Stratagene), starting from 5xMyc-
mBcl2-A1b plasmid described above. Oligonucleotides used to mutagenize the gene 
were:  
NAME DELETION SEQUENCE 
mBcl2-A1b??1 
forward 
(?aa 4?34) ?? ?????????????????????????? 
mBcl2-A1b??1 
reverse 
(?aa 4?34) ?? ?????????????????????????? 
mBcl2-A1b??1-3 
forward 
(?aa 4?64) ?? ??????????????????????????? 
mBcl2-A1b??1-3 
reverse 
(?aa 4?64) ?? ??????????????????????????? 
mBcl2-A1b??7-9 
forward 
(?aa 130?168) ???????????????????????????????? 
mBcl2-A1b??7-9 
reverse 
(?aa 130?168) ???????????????????????????????? 
mBcl2-A1b?9 
forward 
(?aa 150?168) ?? ????????????????????????????? 
mBcl2-A1b?9 
reverse 
(?aa 150?168) ???????????????????????????????? 
 
5xMyc-human Bcl2-A1 (Crosio et al., 2006; Ferri et al., 2006): coding sequence 
corresponding to human Bcl2-A1 (NM_004049.3) was obtained by cloning a PCR 
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hTDP-43WT/Q331K/M337V/A382T: Coding sequences corresponding to human TDP-43 
(NM_007375.3) were isolated by RT-PCR and cloned downstream to 5xMyc repeats 
into XhoI restriction site of the pCS2-MTK vector. Mutants were obtained by 
mutagenesis starting from hTDP-43, using the Quickchange site-directed mutagenesis 
kit (Stratagene), Oligonucleotides used to amplify the gene WT and to mutagenize it 
were: 
NAME SEQUENCE 
hTDP-43WT forward ?? ?TTCTCGAGCCTCTGAATATATTCGGGTAACC?? 






2.1 Preparation of competent cells  
Plated on an agar plate E. coli DH5 ? cells (10 g/L of tryptone, 5 g/L yeast extract, 10 g/L 
NaCl, 15 g/L agar) in the absence of antibiotics. After 12 hours collect a single colony to 
grow for 14-16 hours in 2 ml of LB (10 g/L of tryptone, 5 g/L yeast extract, 10 g/L NaCl) 
at 37 °C in agitation. Inoculate the cells into 100 ml of LB and shake at 37 °C. Check 
bacterial growth by reading in a spectrophotometer at a wavelength of 600 nm until 
reaching an optical density (OD) of 0.4. Centrifuge the cell suspension is at 4000 rpm for 
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10? at 4 °C. Remove supernatant and resuspend the pellet in a volume of 10 ml of CaCl2 
0.1 mM, and centrifuge the cell suspension as above. Resuspend the pellet in 4 ml of 
cold CaCl2 0.1 mM, 10% glycerol, put on ice for 15? and store in aliquots at -80 °C. 
 
2.2 Cell cultures 
NSC cells and SH-SY5Y are cultured in Dulbecco MEM/F12 ground (Gibco BRL), 
HEK293 in Dulbecco MEM, always in the presence of 10% fetal calf serum, free of 
tetracycline contamination (Tet-????? ????? ?????????? ???? ???????????? ??? ??? ??? ???? ?????
Medium contains 100 units/ml penicillin G and 100 ?g/ml streptomycin (Gibco BRL). 
The cells are grown in an incubator at 37 °C in a humidified atmosphere containing 5% 
CO2. Trypsin (0.5 g/ml, 68 mM EDTA) is added to split cells, then diluted in fresh 
medium.  
 
2.3 Tissue dissection 
All animal procedures have been performed according to the European Guidelines for 
the use of animals in research (86/609/CEE) and the requirements of Italian laws (D.L. 
116/92). At early symptomatic stage of the disease (120 days), mice are anesthetized 
with chloral hydrate 500 mg/kg, sacrificed and tissue dissected. Spinal cord is manually 
??????????????????????????????????????????????????are isolated from 1 ml heparinated 
blood samples by standard centrifugation on a Ficoll gradient. All efforts are made to 
minimize suffering. All animals have been raised and crossed in the indoor animal 
house in a 12 h light/dark cycle in a virus/antigen-free facility with controlled 
temperature and humidity and have been provided with water and food ad libitum. 
 
2.4 Use of restriction and modification enzymes 
The digestion reactions are usually assembled with 3 units enzyme/?g DNA and a 
specific buffer. The incubation is performed for one hour at 37 °C. After the digestion 
with appropriate enzymes, vectors are digested, at 37 °C for one hour, by CIP (Calf 
Intestinal Phosphatase,1 unit/?l, Promega), to remove phosphate to 5' ends of the 
linearized plasmid.  
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2.5 Agarose gel electrophoresis 
Dissolve the agarose (1%) in TAE (40 mM Tris-HCl, pH [8.5], 1 mM EDTA, 20 mM 
acetic acid) and add ethidium bromide (EtBr) at a final concentration of 0.04 ?g/ml. 
Dilute samples in water and loading buffer (0.04% bromophenol blue, 0.04% xylene 
cianol, 30% glycerol). Load samples to a voltage of 120V. Visualize Nucleic acid bands 
under UV light. The size of the fragments are estimated in the presence of a ladder of 
known molecular weight. 
 
2.6 DNA purification from agarose gel 
Kit Wizard ® SV Gel and PCR Clean-Up System (Promega) is used to isolate a DNA 
fragment. Following electrophoresis, excise DNA band from gel and place gel slice in a 
1.5 ml microcentrifuge tube. Add Membrane Binding Solution (10?l/10mg of gel slice). 
Vortex and incubate at 50?65°C until gel slice is completely dissolved. Insert SV 
Minicolumn into Collection Tube. Transfer dissolved gel mixture to the Minicolumn 
assembly. Incubate at room temperature for 1?. Centrifuge at 16,000 ×g for 1?. Discard 
flowthrough and reinsert Minicolumn into Collection Tube. Add 700?l Membrane Wash 
Solution (ethanol added). Centrifuge at 16,000 ×g for 1?. Discard flowthrough and 
reinsert Minicolumn into Collection Tube. Repeat Step 4 with 500?l Membrane Wash 
Solution. Centrifuge at 16,000 ×g ??????. Empty the Collection Tube and recentrifuge the 
???????????????????????with the microcentrifuge lid open (or off) to allow evaporation of 
any residual ethanol. Carefully transfer Minicolumn to a clean 1.5 ml microcentrifuge 
tube. Add 50 ?l of Nuclease-Free Water to the Minicolumn. Incubate at room 
temperature for 1?. Centrifuge at 16,000 ×g for 1?. Discard Minicolumn and store DNA at 
4°C or ?20°C. 
 
2.7 Ligation reaction 
Ligase reaction is set up as follows: in a final volume of 15 ?l, incubate 40-80 ng of 
linearized plasmid and a variable quantity of insert in the presence of 1 unit of T4 DNA 
ligase (Promega) in an appropriate buffer (Ligase buffer 10X, Promega). Evaluate, for 
each cloning, the optimal ratio vector/insert for the reaction. After an incubation O/N at 
16°C, transform E. coli DH5 ? cells with 5 ?l of the reaction. 
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2.8 Bacterial transformation 
Add 5 ?l of a ligation reaction to 80 ?l of competent cells. After incubation on ice for ???, 
shock the cells at 37 °C for ??, then incubate at room temperature for ???. Add 500 ?l of 
LB and incubate at 37 °C for ???, centrifuge for few seconds to obtain a pellet and, 
eliminated 500 ml of LB, resuspend the pellet. Plate cells on a selective solid medium 
(LB agar and appropriate antibiotic) and incubate O/N at 37 °C. 
 
2.9 Plasmid DNA purification (Miniprep) 
Wizard®Plus SV Minipreps DNA Purification System (Promega) is used to purify 
plasmidic DNA. Pellet 1?10 ????????????????????????????????????????????????????????????
with 250 ?l of Cell Resuspension Solution. Add 250 ?l of Cell Lysis Solution to each 
sample; invert 4 times to mix. Add 10 ?l of Alkaline Protease Solution; invert 4 times to 
mix. Incubate 5 minutes at room temperature. Add 350 ?l of Neutralization Solution; 
invert 4 times to mix. Centrifuge at top speed for 10? at room temperature. Insert Spin 
Column into Collection Tube. Decant cleared lysate into Spin Column. Centrifuge at top 
speed for 1? at room temperature. Discard flowthrough, and reinsert Column into 
Collection Tube. Add 750 ?l of Wash Solution (ethanol added). Centrifuge at top speed 
for 1?. Discard flowthrough and reinsert column into Collection Tube. Repeat Step 10 
with 250 ?l of Wash Solution. Centrifuge at top speed for 2? at room temperature. 
Transfer Spin Column to a sterile 1.5 ml microcentrifuge tube, being careful not to 
transfer any of the Column Wash Solution with the Spin Column. If the Spin Column has 
Column Wash Solution associated with it, centrifuge again for 1? at top speed, then 
transfer the Spin Column to a new, sterile 1.5 ml microcentrifuge tube. Add 100 ?l of 
Nuclease-Free Water to the Spin Column. Centrifuge at top ?????? ???? ??? at room 
temperature. Discard column, and store DNA at ?20°C or below. 
 
2.10 Transfection of eucariotic cells 
Transient expression of each plasmid (1.5 ?g DNA/5?7×105 cells) is obtained 
transfecting cells with LipofectAMINE LTX and PLUS reagent (Invitrogen). Dilute the 
optimized amount of plasmid DNA in OPTIMEM (Gibco BRL) and add the optimized 
????????????????????????????????????????????????????????????????????????????????????at 
room temperature. Add the optimized volume of ??????????????? ???? ????????? ??? ????
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diluted DNA, incubate for 30? at room temperature. DNA-lipid complexes are stable for 6 
hours at room temperature. Add DNA-lipid complex dropwise to the well containing 
cells, mixing gently. Medium may be changed after 4?6 hours. 
 
2.11 DNA extraction and precipitation  
Add an equal volume of phenol-chloroform-isoamyl alcohol 25:24:1 [pH 8.0] to the lysis 
product. Mix carefully and centrifuge at 12000 rpm ??????? at room temperature. Recover 
the aqueous phase containing DNA. Add 0.1 volumes of 3M sodium acetate [pH 5.5] 
and 2.5 volumes of ethanol (EtOH) absolute to prepitate DNA. Mix by vortex and store 
the sample at -80 °C for ???. Centrifuge ????????? 12000 rpm and wash the pellet with 
EtOH 80% and centrifuge ???? ???? ?? 12000 rpm. Eliminate the EtOH and air-dry the 
pellet. Resuspend in distilled H2O. 
 
2.12 RNA extraction 
Lyse cells directly in a culture dish by adding TRIZOL Reagent (1 ml per 10 cm2) to 
dish, and passing the cell lysate several times through a pipette. Incubate the 
???????????? ???????? ???? ??? at 15-30°C to permit the complete dissociation of 
nucleoprotein complexes. Add 0.2 ml of chloroform per 1 ml of TRIZOL Reagent. Shake 
tubes vigorously ?????????and incubate them at 15-30°C for 2-3?. Centrifuge the samples 
at 12,000 ×g for 15? at 2-8°C. Following centrifugation, the mixture separates into a 
lower red, phenol-chloroform phase, an interphase, and a colorless upper aqueous 
phase. RNA remains exclusively in the aqueous phase. Transfer the aqueous phase to 
a fresh tube. Precipitate the RNA from the aqueous phase by mixing with isopropyl 
alcohol (0.5 ml/1 ml of TRIZOL Reagent). Incubate samples at 15-30°C for 10? and 
centrifuge at 12,000 ×g for 10? at 2-8°C. The RNA precipitate, often invisible before 
centrifugation, forms a gel-like pellet on the side and bottom of the tube. Remove the 
supernatant. Wash the RNA pellet once with 75% ethanol (1 ml/1 ml of TRIZOL 
Reagent). Mix the sample by vortex and centrifuge at 7,500 ×g for 5? at 2-8°C. At the 
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2.13 UV spectrophotometry 
Dilute 5 ?l of sample in 1 ml of H2O into a quartz cuvette. Measure the absorbance at a 
wavelength of 260 nm and 280 nm by spectrophotometry. Absorbance (OD) of the 
sample at 260 nm provides a measure of the amount of nucleic acids present in the 
sample considering 1 OD=50?g/ml for DNA and 1 OD=40 ?g/ml for the RNA, the 
absorbance at 280 nm estimated the amount of protein contaminants. 
 
2.14 Reverse transcription reaction 
The reverse transcription reaction is set up as follows: 
RNA 1?? 
Random primers (100ng/??? 1,25?? 
Incubate for 5 minutes at 65-75 °C. 
 
First-strand Buffer 5X ???? 
DTT 0.1 M ?????? 
dNTPs 2mM ?????? 
SuperScript II RT (200 U/?l) ?????? 
RNase OUT (40U/??? 0,5 ?? 
H2O ???????? 
 
Incubate ?? at room temperature, one hour at 37 °C and 5? at 95 °C to inactivate reverse 
transcriptase. 
 
2.15 PCR reaction 
The PCR reaction to amplify gene is set up in the following manner: 
DNA/cDNA 2 ?? 











Oligonucleot????????????????? 1 ?? 
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Pfu Turbo Buffer 10x (Stratagene)  
 
2,5 ?? 














To 25 ?? 
 
Amplification conditions are:  
1. ????????????? 
2. ????????????????? denaturation,  
3. ???? at the specific annealing temperature of the primer,  
4. ?? at 72 °C per kb of DNA for the extension  
5. ?????????????  
Steps 2-3-4 are repeated for 30 cycles 
 
2.16 Detection of Bcl2-A1 subtype mRNA by RT-PCR  
Bcl2-A1a, Bcl2-A1b, Bcl2-A1d are amplified from mouse cDNA, obtained by retro-
transcription of spinal cord and lymphocyte total RNA from SOD1G93A transgenic mouse 
and control mice. Specific primers for all the three mRNAs are used for the amplification 
??? ???????????????????????? ????????????????????????????? product is 
analyzed by single and double digestion with Pst I and Bgl II. 
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2.17 Luciferase assay 
Lyse transfected NSC-34 cells in Lysis Reagent (25 mM Tris-phosphate [pH 7.8], 2 mM 
DTT, 2 mM 1.2-diaminocyclohexane-?????????-tetraacetic acid, 10% glycerol, 1% Triton 
X-100). Incubate equal amount of protein extracts with 100 ?l of Luciferase Assay 
Reagent (Promega) and determine luminescence using the Victor 5 Wallace 
workstation (PerkinElmer) according to manufacturer's instruction. 
 
2.18 GST pull-down assay 
Express the GST-Bcl2-A1 fusion protein in E. coli BL21. After induction with 0.5 mM 
IPTG for 3 h at 30 °C, collect bacteria, wash twice in PBS 1X and lyse in lysis buffer (50 
mM Tris HCl [pH 8.0], 1 mM EDTA, 150 mM NaCl, 1% Triton X100, 1 mM PMSF, 
protease inhibitor cocktail 1X, lysozime 200 ?g/ml). Keep bacterial cell lysates on ice for 
???? ???? sonicate ???? ??? ??? ????? ???? ?? ?? ??? Purify GST-proteins on glutathione?
Sepharose 4 fast flow resin (GE Healthcare). Incubate aliquots (500 ng) of GST-Bcl2-A1 
or GST alone with 2 mg of total spinal cord protein extracts from SOD1G93A transgenic 
mice, obtained by homogenization in lysis buffer (50 mM Tris?HCl [pH 8.0], 150 mM 
NaCl, 1% NP-40, 1 mM PMSF, protease inhibitor cocktail 1X). After an overnight 
incubation at 4 °C, collect GST-Bcl2-A1 or GST alone by adding to the mixture 10 ?l of 
glutathione-Sepharose 4 fast flow resin for 2 h at 4 °C. After five washes in lysis buffer, 
resuspend the beads in Laemmli Buffer 1X (50 mM Tris-HCl [pH 6.8], 1% ?-
mercaptoethanol, 10% glycerol, 1% SDS, bromophenol blue) and load on SDS/PAGE 
acrylamide gel. Stain SDS/PAGE loaded with GST-pulldown with Mass Compatible 
Super Blue Stain Kit (Nurex srl, Sassari) or analyzed by Western blot as described 
below.  
 
2.19 In-gel digestion and matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometry (MS) analysis  
Excise proteins of interest with a sterile scalpel and destain with 100 ?l of 5 mM 
NH4HCO3/50% acetonitril. Dehydrate gel pieces with acetonitrile, dry at room 
temperature and reswoll with 10 ?l of 5 mM NH4 HCO3 containing 10 ng/?l trypsin for 
??? on ice. Subsequently, remove excess of digestion buffer and substitute with an 
equal volume of 5 mM NH4HCO3. Conduct tryptic digestion over night at 37 °C. Store 
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the peptide mixtures at 4 ?C. Mix the peptides extracted from the gel pieces with an 
equal volume of 10mg/ml ?-cyano-4-hydroxy-cinnamic acid in 40% (v/v) 
acetonitrile/0.1% (v/v) trifluoroacetic acid and apply the mixed solution as a 
microcrystalline thin film onto a 96-spot MALDI target. Performe MALDI-MS using a 
Micromass Tof-Spec 2E spectrometer (Manchester, UK), equipped with a 337nm 
nitrogen laser. The instrument operates in the positive ion reflectron mode at 20 kV 
accelerating voltage with time-lag focusing. Each mass spectrum is generated by 
accumulating data from 100 to 120 laser shots (Lepedda et al., 2009). The MS spectra 
acquired is submitted to MASCOT (Matrix Science, London UK). 
 
2.20 SDS-PAGE and Western blot analyses 
Prepare protein extracts by addition of Laemmli buffer (50 mM Tris-HCl, pH [6.8], 1% ?-
mercaptoethanol, 10% glycerol, 1% SDS, bromophenol blue), denature at 95 °C for ?? 
and resolve by standard SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Load 
protein extracts in a stacking gel 4% acrylamide/bisacrilamide (37.5:1) and in a running 
gel. Perform electrophoresis in running buffer (25 mM Tris HCl, pH [7.8], 200 mM 
glycine, 0.1% SDS), by applying a current of 80 V for the stacking or 100 V for the 
running gel. Analyze proteins by Western blot: electroblot samples onto Protan 
nitrocellulose (Schleicher & Schuell GmbH). Incubate membranes for 16 h at 4°C with 
3% low-fat milk in PBS 1X/Tween-20 0.05 % solution and the following antibodies: anti-
Flag M2 monoclonal antibody (Sigma-Aldrich), anti-myc monoclonal antibody 9E10 
(Sigma-Aldrich), anti-?actin monoclonal antibody AC-15 (Sigma-Aldrich), rabbit 
polyclonal anti-Cu-ZnSOD antibody (Stressgen), rabbit polyclonal anti-human MnSOD 
antibody (Stressgen), rabbit anti-cleaved caspase-3 (Cell signaling), rabbit anti-
caspase-3 (Cell signaling), rabbit anti-PARP (Cell signaling), rabbit anti-CREB (Cell 
signaling). Secondary antibodies (peroxidase-conjugated) are obtained from Invitrogen. 
After membrane washing, visualize proteins by enhanced chemioluminescence (GE 
Healthcare) followed by Densitometric analyse, performed using Quantity One software 
program (Bio-Rad Laboratories) and normalized against the signal obtained by re-
probing the membranes with an antibody against mouse ?-actin. Student's t test is used 
for data analysis and differences is considered statistically significant if pb0.05. All 
statistical computations is performed using GraphPad Prism 4.0 (GraphPad Software). 
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2.21 Immunoprecipitations 
At 48 h after transfection, lyse HEK293 cells in 1 ml of lysis buffer. After centrifugation at 
12,000 g for 10 min at 4 °C, pre-clear the supernatants at 4 °C for 1 h with protein A-
Sepharose. Add the anti-Myc or the anti?Flag antibodies at 1:1000 dilution, and after an 
overnight incubation at 4 °C, collect the immunoprecipitates by adding 20 ?l of protein 
A-Sepharose. Wash the beads five times in lysis buffer, resuspend in Laemmli Buffer 
1X and analyze by Western blotting. 
 
2.22 Subcellular fractioning 
5×106 HEK293 are transfected with plasmids coding for WT or the deletion mutant ??9 
of murine Bcl2-A1 and the human Bcl2-A1. 48 h after transfection harvest cells, wash in 
1 ml of ice-cold PBS 1X with 1 mM EDTA and centrifuge ??? ???? ??? ???? ??? ??? ?? ????
Solubilize the pellet in 1 ml of mitochondrial buffer (210 mM mannitol, 70 mM sucrose, 1 
mM EDTA, 10 mM Hepes-KOH [pH 7.5]) containing protease inhibitors cocktail (Sigma-
Aldrich). Store 50 ?l of the solubilized (total) fraction and homogenize the remaining in a 
glass-teflon potter homogenizer (10?15 strokes) and centrifuge ??????????????????????????
Harvest the supernatant and centrifuge again in the same conditions. Following an 
??????????????????????????????????????????????????????? collect the supernatant (cytosolic 
fraction) and wash the mithocondrial pellet in 1 ml of mitochondrial buffer and centrifuge 
at ???????????????????????????Resuspend the pellet carefully in 100 ?l of lysis buffer (50 
mM Tris?HCl [pH 8.0], 150 mM NaCl, 1% NP- 40) and protease inhibitors, incubate for 
???? ??? ???? ???? ??????????? ??? ??????? ??? ???? ???? ??? ?? ???? store the supernatant 
(mitochondrial fraction) ??? ???? ???? Evaluate protein concentration using Coomassie 
Protein Assay Reagent (Fluka Analytical) and load 10 ?g of each fraction on 
SDS/PAGE followed by Western Blot analysis. 
 
2.23 Nuclear-cytoplasmic separation of TDP-43 
1×106 SH-SY5Y are transfected or not (-) with a plasmid coding for WT or mutants 
Q331K-M337V-A382T of TDP-43. 48 h after transfection wash cells twice with cold PBS 
1X, harvest in 500 ?l ????????????????????????????????????????????????????????????????
pellet gently in 500 ?l of S1 buffer (10 mM Hepes [pH 7.9], 10 mM KCl, 1,5 mM MgCl2, 
0,1 mM EGTA [pH 7.0], 1 M DTT (1 ?l/2ml), syringe ten times at 4 °C, centrifuge at 
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????? ???? ???????????? ??, collect supernatant (cytoplasmic fraction) and resuspend the 
pellet gently in 500 ?l of S1 buffer. Centrifuge ??????????????????????????????????????????
pellet with 30 ?l ??????????????????????????????????????????????????????????????????????????
collect the supernatant (nuclear fraction).  
 
2.24 TDP-43 solubility  
1×106 SH-SY5Y are transfected or not (-) with a plasmid coding for WT or mutants 
Q331K-M337V-A382T of TDP-43. 72 h after transfection scrape cells off the plate in 
culture medium, collect by centrifugation, wash with PBS 1X, and resuspend in 500 ml 
of buffer A (10mM Tris-HCl [pH 8.0], 1mM EDTA [pH 8.0], 100mM NaCl, 1% Triton X-
100 containing protease inhibitors cocktail (Sigma-Aldrich). After 10 min of ice 
incubation, centrifuge the lysates at 20,000 g for 10?, and collect the supernatants as 
detergent soluble fractions, whereas wash the pellet (insoluble fractions) in buffer A, 
centrifuge again as before and resuspend in 150 ?l of Laemmli buffer 1X. 
 
2.25 Immunofluorescence 
Wash 1×105 NSC-34 cells, grown on a cover-glass, twice with PBS 1X and then fix with 
1 ml of 4% paraformaldehyde/PBS 1X for 10?. Permeabilize cells with 0.1% Triton X-100 
in PBS and block non-specific binding with 5% bovine serum albumin, 0.1% Triton X-
100 diluted in PBS for 1 h at room temperature. Incubate cells with primary antibodies 
(mouse anti-myc diluted 1:1000, Sigma-Aldrich, rabbit anti-MnSOD diluted 1:2000, 
Stressgene) diluted in blocking solution, overnight at 4 °C and then with secondary 
antibodies Alexa 594- and Alexa 488-conjugated (Molecular Probe, Invitrogen) diluted 
1:1000 in blocking solution for 1 h at room temperature. Analyze cells with a Leica TCS 
SP5 confocal microscopy with LAS lite 170 image software. 
 
2.26 In vitro assay for caspase-3 activation  
To test caspase-3 activation in vitro I use a protocol modified from Deveraux et al. 
(1997). Incubate aliquots of 2 ?g of HEK293 cells transfected with Flag-pro-caspase-3 
with scalar quantity of myc immunoprecipitates ?????????????????????????????????????????
with 5xmyc-?????????????????????????????????????????????????l. Add 50 ng of recombinant 
active caspase-8 (Sigma-Aldrich) and incubate the ??????????????????????????????????????
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Stop the reactions by adding of 6 ?l Laemmli Buffer 5X. The samples are finally 
analyzed by Western Blot.  
 
2.27 Assessment of cell death 
Quantification of apoptotic cells is obtained by direct visual counting after nuclear 
staining of 4% paraformaldehyde-fixed cells with the fluorescent probe Hoechst 33342 
(1 ?g/ml, Sigma). One hundred cells is analyzed in each examined field at 20× 
magnification, and eight randomly chosen fields for each experimental condition are 
counted. Only the cells containing clearly picnotic or fragmented nuclei are considered 
apoptotic. 
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Theme 1: Molecular dissection of Bcl2-A1 role during ALS 
onset and progression in SOD1 models of the disease 
Expression of mutant SOD1 typical of familial amyotrophic lateral sclerosis induces the 
expression of Bcl2-A1, a member of the Bcl2 family of proteins, specifically in motor 
neurons of transgenic mice. In this work, I have used immortalized motor neurons 
(NSC-34) and transgenic mice expressing mutant SOD1 to unravel the molecular 
mechanisms and the biological meaning of this up-regulation. I report that up-regulation 
of Bcl2-A1 by mutant SOD1 is mediated by activation of the redox sensitive transcription 
factor AP1 and that Bcl2-A1 interacts with pro-caspase-3 via its C-terminal helix ?9. 
Furthermore, Bcl2-A1 inhibits pro-caspase-3 activation in immortalized motor neurons 
expressing mutant SOD1 and thus induction of Bcl2-A1 in ALS mice represents a pro-
survival strategy aimed at counteracting the toxic effects of mutant SOD1. These data 
provide significant new insights on how molecular signaling, driven by expression of the 
ALS causative gene SOD1, affects regulation of apoptosis in motor neurons and thus 
may have implications for ALS therapy, where prevention of motor neuronal cell death is 
one of the major aims. 
 
1. Mutant SOD1 induces Bcl2-A1 expression via AP1 
It has been demonstrated that Bcl2-A1 is specifically induced in motor neurons of 
SOD1G93A mice (Crosio et al., 2006). Since mice have multiple Bcl2-A1 genes (the 
isoforms -a, -b and -d consist of two exons and encode a full length protein, while 
isoform -c lacks putative exon 2 and it is most likely a pseudogene), in a preliminary 
experiment I carried out the classification and relative quantification of Bcl2-A1a, -A1b 
and -A1d mRNA subtypes in spinal cord and lymphocytes of mice expressing wild-type 
(WT) or mutant (G93A) SOD1. Semiquantitative RT-PCR shows that Bcl2-A1 is induced 
only in the spinal cord of SOD1G93A mice, since lymphocytes of both genotypes have 
comparable levels of Bcl2-A1 mRNA (Fig. 1A). The amplicons were subjected to 
digestion with restriction enzymes that allow discrimination of Bcl2-A1 isoforms, as 
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reported by Hatakeyama et al. (1998) (Fig. 1B). In the spinal cord, all three isoforms are 
induced, although isoform A1b is clearly the most abundant (Figs. 1C and D). Previous 
reports have demonstrated that the human and murine Bcl2-A1 promoter is 
physiologically regulated via NF-?B transcription factor in T cells (Edelstein et al., 2003; 
Grumont et al., 1999). 
 
 
Fig. 1. Relative expression level of each Bcl2-A1 subtype in spinal cord of SOD1G93A mice. A: 
Semiquantitative RT-PCR on 1 ?g of total RNA extracted from spinal cord and lymphocytes of two mice, 
expressing human either wild type (WT, mice 1 and 2) or mutant (G93A, mice 3 and 4) SOD1. PCR was 
performed using oligos indicated by arrows in panel B to amplify all the Bcl2-A1 mRNA isoforms; 
amplification of GAPDH was used as po???????????????????????????????????????????????????????????
Schematic representation of murine Bcl2-A1 mRNA isoforms. Arrows indicate the position of oligos 
utilized for PCR, while vertical lines point at PstI and BglII restriction sites. C: Representative experiment 
showing the digestion product of RT-PCR amplicons obtained from SOD1G93A spinal cord RNA; PCR 
???????????????????????????????????????????????????????????????????????????????????????????????????????????
(lanes P+B). Major fragments were as follows: 743 bp fragments, A1b (lane B); 602 bp fragments, A1a or 
A1d (lanes B and P/B); 586 bp fragments, A1b or A1d (lane P) and A1-d (lanes P and P/B); 495 
bpfragments,A1a (lanes P and P/B). RNA(1 ?g) isolated from lymphocytes or spinal cord of SOD1G93A 
mice was reverse transcribed and amplified. RT-PCR products were digested by restriction enzymes as 
indicated above, electrophoresed on 1.3% agarose gels and D: the relative amount of each mRNA as 
evaluated by densitometric analysis. 
 
Moreover, the assembly of an enhanceosome-like complex, in which cooperative 
protein?protein and protein?DNA interactions involving NF-?B and AP1 binding sites 
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concur to the efficient formation of the transcriptional complex, has been observed on 
the human Bcl2-A1 promoter (Edelstein et al., 2003). Using a bioinformatics approach 
(Cartharius et al., 2005), I was able to identify a potential AP1 site on murine Bcl2-A1b 
promoter, located upstream to NF-????????????????????????????????????????????????????????
?512) compatible with the formation of an enhanceosome-like complex. I therefore 
cloned murine Bcl2-A1b promoter in a wild type form or with either a mutagenized NF?B 
or a mutagenized putative AP1 binding site upstream a luciferase reporter gene (Fig. 
2A). These plasmids were used to transfect motor neuronal NSC-34 cells and, as 
expected, mutations of NF-?B, but also on the putative AP1 binding sites on murine 
Bcl2-A1b promoter impair induction upon TNF? stimulation (Fig. 2B). In contrast, 
induction of Bcl2-A1b upon mutant SOD1 expression is AP1-dependent and NF-?B-
independent (Fig. 2C). The above experiments show a direct link between mutant 
SOD1 expression and Bcl2-A1 induction in motor neurons and that this induction is 
dependent on the activation of transcription factor AP1.  
 
 
Fig. 2. SOD1G93A induces Bcl2-A1b expression via AP1 transcription factor. A: Schematic diagram of the 
Bcl2-A1??????????????????????????????????????????????????????????????? the luciferase reporter plasmid 
pGL2-Basic. The white open box represents the NF-?B-binding ????????-AGGGGATCCC-??????????????????
??? ???? ????????? ??? ???? ???????? ?????? ???-AGGTCATAAC-???? ??????ted by PCR; the gray open box 
represents the putative AP1-????????????????-GGTGAGTGACT-??????????????????????????????????????????-
GGTAAAAGACT-????? ?????????? ???????? ???? ?????????????? ??????????? ?????? ??????-34 motoneuronal cells 
transfected with the indicated plasmids were harvested 24 h post-transfection and analyzed for luciferase 
activities. Mutagenesis of both AP1 and NF-?B binding sites impairs TNF? induction of Bcl2-A1b. 
Luciferase values obtained in basal ?????????????????????????????????????????????ue of 1.0 and activation 
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represents the relative normalized luciferase activities obtained upon treatment with TNF? (10 ng/ml for 8 
h), (n-fold). C: SOD1G93A-mediated induction of Bcl2-A1b requires AP1, but not NF-?B binding site; NSC-
34 cells were transfected as in B; luciferase values obtained by co-transfection with pCMV-SOD1WT were 
arbitrarily assigned a value of 1.0 and activation represents the relative normalized luciferase activities 
obtained upon co-transfection with pCMV-SOD1G93A plasmids (n-fold). The data are rapresentative of 
three independent experiments. 
 
2. Bcl2-A1 interacts with pro-caspase-3  
In order to get insight on Bcl2-A1 molecular mechanism of action, I looked for molecular 
interactors of Bcl2-A1 in motor neurons, using an approach of GST-pull down coupled 
to mass spectrometry. We cloned the mouse Bcl2-A1 (b isoform) coding sequence at 
the C-terminal of GST sequence in the prokaryotic pGEX-3 expression vector and used 
this plasmid to transform E. coli. Induction with IPTG leads to a significant expression of 
GST-Bcl2-A1 fusion protein (Fig. 3A). The fusion protein, isolated under native 
conditions by a single step of purification using a Glutathione Sepharose Fast Flow 
column, has been used in GST-pull down experiments using total protein extracts from 
spinal cord of SOD1G93A mice. The proteins associated with GST-Bcl2-A1 were 
separated by SDS-PAGE (Fig. 3B) and identified by MALDI-MS. The analysis of MS 
spectra led to the identification of pro-caspase-3 as a candidate protein (pb0.05). To 
confirm the Bcl2-A1/pro-caspase-3 interaction in vitro I performed a GST-pulldown 
experiment followed by Western blot using a specific antibody against caspase-3. As 
shown in Fig. 3C, GST-Bcl2-A1 is able to pulldown specifically pro-caspase-3, since no 
interaction is detected using GST alone. 
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Fig. 3. Identification of pro-caspase-3 as Bcl2-A1 interactor. A: Expression and purification of GST-Bcl2-
A1 and GST from E. coli BL21 cells. M = molecular marker expressed in kD (Prestained Protein 
Molecular Marker. Fermentas); t0 = total protein extract before induction; T = total protein after 2 h 
induction with IPTG 0.5 mM; P = purified recombinant protein. B: 500 ng of GST-Bcl2-A1 or GST alone 
were bound to glutathione sepharose and then incubated with 2 mg of proteins from SOD1G93A spinal 
cord (indicated as Ext). Proteins bound to GST-Bcl2-A1 or GST alone were isolated by SDS-PAGE. The 
gel was stained with high sensitive colloidal Coomassie and the protein precipitated by GST-Bcl2-A1 
(indicated with an asterisk) was identified by mass spectrometry. C: The presence of pro-caspase-3 in the 
bound fraction was verified by immunoblotting. 
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In order to evaluate whether I could detect a direct interaction between Bcl2-A1 and pro-
caspase-3 also in vivo, I performed a series of co-immunoprecipitation experiments. I 
cloned murine pro-caspase-3 downstream to 3xFlag epitope and I observed that, when 
transfected in HEK293 cells, the Flag-tagged protein can be normally processed and 
activated upon induction of apoptosis by staurosporine (Fig. 4A). Then I co-transfected 
HEK293 cells with plasmids coding for myc-Bcl2-A1 and Flag-pro-caspase-3. Co-
immunoprecipitation experiments demonstrated that using specific antibodies for each 
of the two proteins we can immunoprecipitate the other one (Fig. 4B). The observed 
interaction of murine Bcl2-A1 with murine pro-caspase-3 was confirmed also for their 
human counterparts in both HEK293 and NSC-34 cells (Fig. 4C).  
 
 
Fig. 4. Bcl2-A1 binds to pro-caspase-3. A: N-terminal fusion of 3xFlag repeats to pro-caspase-3 does not 
impair its normal processing. HEK293 cells were transfected with 3xFlag-procaspase-3 and 24 h post-
?????????????????????????????????????????M staurosporine for additional 5 h. Protein extracts were analyzed 
by Western blot with antibodies against Flag, caspase-3, active caspase-3 and ??actin. B: HEK293 cells 
were transiently transfected with the indicated constructs. Two days later the cells were lysed in NP-40 
buffer. Lysates were immunoprecipitated with an anti-Flag antibody or anti-Myc antiserum. Precipitates 
(IP) were analyzed by Western blot with anti-Myc or anti-Flag antibody, respectively. The levels of 
transfected proteins were visualized by Western blot on cell lysates used for the co-immunoprecipitation. 
C: plasmids coding for the Homo sapiens homologues of Bcl2-A1 and pro-caspase-3 were transfected in 
HEK293 or NSC-34 cells and the samples were processed as in B. 
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3. Bcl2-A1 interacts with pro-caspase-3 via its C-terminal helix ?9 
Bcl2-A1 has a helical structure typical of that seen in other Bcl-2 proteins (Brien et al., 
2009; Smits et al., 2008). Different lines of evidence indicate that Bcl2-A1 may coexist in 
two distinct conformational states and that the amphipathic helix ?9 at the C-terminal of 
the protein is required both for the anchorage to mitochondria and to regulate the anti-
apoptotic function (Brien et al., 2009; Duriez et al., 2000; Ko et al., 2007, 2011; Smits et 
al., 2008). To investigate the contribution of the different Bcl2-A1 sub-regions to the 
binding with pro-caspase-3, I generated four different deletion mutants (indicated as 
??1, ??1?3, ??7?9 and ??9, Fig. 4A), in fusion with the myc epitopes and expressed in 
HEK293 cells. Co-immunoprecipitation experiments on total extracts from these cells 
demonstrate that the helix ?9 is required for the interaction with pro-caspase-3. 
Moreover, the lack of helix ?1?3 strongly increases the binding to pro-caspase-3, 
probably because the deletion encompasses the BH3-binding cleft in which helix ?9 can 
shift in and out (Brien et al., 2009) (Fig. 5B). Since helix ?9 of Bcl2-A1 is required for 
both caspase-3 and mitochondria binding, I analyzed the distribution of wild-type or ??9 
Bcl2-A1 in the cytoplasmic and mitochondrial compartments. Immunofluorescence 
analysis on NSC-34 transfected cells shows that wild type Bcl2-A1 is distributed both 
free in the cytoplasm and anchored to associate with mitochondria membrane (Fig. 5C). 
This distribution is further confirmed by Western blot on purified cytoplasmic and 
mitochondrial protein fractions (Fig. 5D). In agreement with published data (Brien et al., 
2009; Duriez et al., 2000), my experiments indicate that Bcl2-A1 is in equilibrium 
between the cytoplasmic and mitochondrial fractions although mainly anchored to the 
mitochondrial membrane and that the deletion ?9 helix moves this equilibrium towards 
the soluble cytoplasmic fraction.  
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Fig. 5. Bcl2-A1 interacts with pro-caspase-3 via helices ?9. A: Schematic representation of Bcl2-A1 
deletion mutants. B: Co-immunoprecipitation was performed as described in Fig. 4B. C: Confocal 
microscopy analysis of NSC-34 cells transfected with human or mouse Bcl2-A1 or mouse Bcl2A1-??9. 
Antibodies against MnSOD were used for mitochondria staining. The yellow color shows the co-
localization of the indicated Bcl2-A1 protein variant with mitochondria. D: Cytosolic (C) or mitochondrial 
(M) protein extracts were prepared from transiently transfected HEK293 as in panel C. The presence of 
Bcl2-A1 protein was assessed by Western blot on 20 ?g of protein samples using antimyc antibody. 
MnSOD is a marker of mitochondrial fractions. 
 Pagina 64 
Maria Elena Mura 
Molecular mechanisms involved in Amyotrophic Lateral Sclerosis: 
 role of Bcl2-A1 and TDP-43 genes in motor neuron degeneration  
Tesi di dottorato in Scienze Biomolecolari e Biotecnologiche 
Università degli studi di Sassari 
 
4. Bcl2-A1 inhibits pro-caspase-3 activation in vitro and in vivo  
To further explore the functional relevance of Bcl2-A1/procaspase-3 interaction I used 
an in vitro approach, evaluating the effect of Bcl2-A1 on pro-caspase-3 processing in 
the presence of recombinant caspase-8. Incubation of recombinant caspase-8 and 
protein extracts containing caspase-3 leads the caspase-3 proteolitic processing that is 
readily detected by a specific antibody against the active form of caspase-3 (compare 
lanes 1 and 2 of Fig. 6A and relative quantification in Fig. 6B). Addition of Bcl2-A1, 
immunoprecipitated from transfected eukaryotic cells, to the reaction mixture inhibits 
procaspase- 3 activation in a dose-dependent manner (Fig. 6A), suggesting a novel 
Bcl2-A1-dependent anti-apoptotic mechanism of action. In order to investigate the anti-
apoptotic contribution of helix ?9 against SOD1G93A induced toxicity, I co-transfected 
NSC-34 motoneuronal cells with Flag-pro-caspase-3 in the presence of WT or mutant 
Bcl2-A1 and in presence or absence of SOD1G93A. In agreement with my previous 
results, Bcl2-A1 is protective against SOD1G93A induced toxicity, as indicated by the 
impairment of Flag-caspase-3 decrease (compare lanes 5 and 6 in Fig. 6C and relative 
quantification in Fig. 6D). This anti-apoptotic effect relies both on presence of helix ?9 
and helix ?1-3 (Figs. 6C and D). The loss of anti-apoptotic activity of ??1-3 is not 
surprising since although this protein binds more tightly to pro-caspase-3 (Fig. 5B), the 
missing domains are also involved in vivo in the maintenance of the pro-apoptotic 
protein Bax in an inactive state (Simmons et al., 2008). Finally I show that caspase-3 
cleavage parallels with an increase in its activity by analyzing PARP cleavage (Fig. 6E) 
and by counting apoptotic nuclei (Fig. 6F). 
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Fig. 6. Effect of Bcl2-A1 binding on pro-caspase-3 maturation in vitro and in vivo. A: Bcl2-A1 impairs in 
vitro pro-caspase-3 activation by caspase-8. Aliquots of 2 ?g of cell extracts from HEK293 transfected 
with Flag-pro-caspase-3 were incubated with increasing concentrations of immunoprecipitates with anti-
myc antibody from HEK293 either transfected with Myc-Bcl2-A1 or untransfected, in presence or absence 
of recombinant caspase-8. Note that immunoprecipitated Myc-Bcl2-A1 is in the nmolar range. The 
caspase-3 activation was analyzed by Western blot with a specific antibody that recognizes only the 
active form. Antibodies against Flag and Myc were used as control for total caspase-3 and Bcl2-A1 
presence. B: Quantification of the experiments in (A) by densitometric assay. Results obtained from 
samples containing only caspase-8 were defined as 100%. Results are expressed as the mean±SEM of 
three independent experiments. ***=pb0.001. C: Deletion of ?9 helix of Bcl2-A1 impairs its anti-apoptotic 
properties. Flag-pro-caspase-3 and the indicated Bcl2-A1 constructs were transfected in NSC-34 cells in 
???????????????????????????????????????????????G93A. 48 h after transfection cell lysates were subjected to 
SDS?PAGE and analyzed by Western blot with the indicated antibodies. D: Quantification of the 
experiments in (C) by densitometric assay. Results obtained from sample not transfected with SOD1G93A 
were defined as 100%. Results are expressed as the means±SEM of three independent experiments. 
??????????????????????????????????????????????????????????????????????????????G93A. Deletion of ?9 helix 
of Bcl2-A1 results in PARP activation, compared to WT Bcl2-A1, in the presence of SOD1G93A. 48 h after 
transfection in NSC-34, cell lysates were subjected to SDS?PAGE and analyzed by Western blot with the 
indicated antibodies. * indicates cleaved PARP. F: Cells as in E were stained with Hoechst 33342 to 
assess cell death. Quantitative analysis of apoptotic nuclei is shown as mean±SEM of n=3 independent 
experiments. 
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This study demonstrates that mutant SOD1 induces the expression of Bcl2-A1, which 
plays an important role in the modulation of caspase-3 activity, in a cell-specific manner 
via AP1 transcription factor (Fig. 7).  
 
 
Fig.7. Up-regulation of Bcl2-A1 by mutant SOD1 is mediated by activation of the redox sensitive 
transcription factor AP1 and that Bcl2-A1 interacts with pro-caspase-3 via its C-????????? ?????? ????
Furthermore, Bcl2-A1 inhibits pro-caspase-3 activation in immortalized motor neurons expressing mutant 
SOD1 and thus induction of Bcl2-A1 in ALS mice represents a pro-survival strategy aimed at 
counteracting the toxic effects of mutant SOD1. 
 
Bcl2-A1 is a member of the Bcl2 family, the key regulators of the mitochondria-
dependent apoptotic pathway and of outer mitochondrial membrane integrity (Chipuk et 
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al., 2010). Different lines of evidence link Bcl2-A1 overexpression to ALS, indicating that 
injured motor neurons may counteract damage by overexpressing an anti-apoptotic 
protein such as Bcl2-A1 (Crosio et al., 2006; Pun et al., 2006). Bcl2-A1 over-expression 
in ALS mice model is limited to spinal cord and it is directly linked to mutant SOD1 
expression (Figs. 1 and 2), with a pattern that mirrors the tissue specificity of the 
disease. Although Bcl2-A1 is mainly expressed in lymphocytes, the present study 
indicates that constitutive mutant SOD1 over-expression does not modify either the 
expression level or the relative isoform abundance in this cell type. Moreover, in 
immortalized motoneurons Bcl2-A1 is transcriptionally regulated by the redox sensitive 
transcription factor AP1, most likely contributing to lineage- and stimulus-dependent cell 
specificity of Bcl2-A1 transcription. In fact, it was previously demonstrated that Bcl2-A1 
is transcriptionally regulated by NF?B in lymphocytes through B- or T-cell receptor 
activation (Grumont et al., 1999; Zong et al., 1999), by NFAT in mast cells activated 
through Fc?RI crosslinking (Ulleras et al., 2008) and by PU.1 during neutrophil 
differentiation (Jenal et al., 2010). The AP1 binding site, already characterized in the 
human Bcl2-A1 promoter, was demonstrated to be relevant for the assembly of an 
enhanceosome-like complex in PMA ionomycin-treated Jurkat T cells (Edelstein et al., 
2003). 
The involvement of AP1 in motor neuron degeneration in ALS is not surprising 
considering that different proteins belonging to the c-Fos, c-Jun and ATF families are 
activated in this disease: (i) ATF3 and phospho-c-Jun have been detected in spinal cord 
and brainstem neurons in SOD1G93A mice, and they can be considered effective 
markers to identify motor neurons in an early phase of their degeneration (Vlug et al., 
2005; Jaarsma et al., 1996); (ii) CSF from ALS patients seems to stimulate Fos 
expression in certain populations of spinal neurons via the NMDA receptors (Manabe et 
al., 1999); (iii) c-Jun activation has been identified in post-mortem ALS spinal cord 
specimens (Virgo and de Belleroche, 1995). Interestingly, using a GST-pull down 
approach combined to mass spectrometry we were able to identify pro-caspase 3 as a 
binding partner for Bcl2-A1. This interaction is highly specific both in vivo and in vitro 
and it depends on Bcl2-A1 helix ?9 (Figs. 5 and 6). This amphipathic carboxy-terminal 
helix was shown to regulate the localization and the pro-survival function of both murine 
(Smits et al., 2008) and human (Brien et al., 2009) Bcl2-A1. Molecular modeling of Bcl2-
A1 indicates that helix ?9 may adopt two distinct conformational states. In one of these 
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states, helix ?9 is located in the hydrophobic binding groove and gives rise to a compact 
molecule: in this conformation helix ?9 may play a regulatory role by limiting the access 
to the hydrophobic BH3-binding cleft. In a second conformation, the molecule is more 
extended, with helix ?9 protruding from the globular core of the protein and therefore 
potentially mediating interactions with membranes and pro-apoptotic proteins such as 
Bak (Brien et al., 2009; Smits et al., 2008). According to this model, we have shown that 
both murine and human Bcl2-A1 are partially localized in mitochondria via helix ?9 (Fig. 
5), although the anchorage is not fully dependent on this region. In fact, deletion of helix 
?9 increases the percentage cytoplasmatic Bcl2-A1, but does not fully prevent binding 
to mitochondria, indicating that Bcl2-A1 subcellular localization relies on multiple factors. 
Bcl2-A1 seems to be a highly versatile protein, displaying different biological effects 
according to the cellular models and toxic insult. Wild-type Bcl2-A1 shows anti-apoptotic 
effects in many different experimental systems, including haematopoietic, tumor and 
neuronal cell lines, independently from the toxic stimulus and from the fusion partner 
(Brien et al., 2009; Crosio et al., 2006; D'Sa-Eipper and Chinnadurai, 1998; Ko et al., 
2007; Kucharczak et al., 2005; Simmons et al., 2008). Deletion of the C-terminal domain 
corresponding to helix ?9, on the contrary, seems to have a dual effect increasing 
(Kucharczak et al., 2005) or decreasing/impairing (Herold et al., 2006; Ko et al., 2007; 
Simmons et al., 2008) Bcl2-A1 anti-apoptotic activity according to cell type and stimulus. 
This contradictory experimental data can be explained considering that Bcl2-A1 can be 
regulated at multiple levels: (i) at transcriptional level; as described above, Bcl2-A1 is 
regulated by many different transcription factors (NF?B, NFTA, AP1, PU.1) enabling 
different cell types to quickly respond to apoptotic insults (Edelstein et al., 2003; Jenal et 
al., 2010; Kim et al., 2004; Ulleras et al., 2008;Wang et al., 1999; Zong et al., 1999); (ii) 
post-transcriptionally, via alternative splicing to produce in human cells a shorter form 
(Ko et al., 2003); (iii) post-translationally by ubiquitin mediated proteasomal degradation 
in human haematopoietic cells and tumors (Fan et al., 2010; Herold et al., 2006; 
Kucharczak et al., 2005); (iv) via interaction with multidomain and BH3-only pro-
apoptotic proteins (Chen et al., 2005; Herman et al., 2008; Simmons et al., 2008; Smits 
et al., 2008;Werner et al., 2002). Here we also provide evidence of a new anti-apoptotic 
Bcl2-A1 mechanism of action. Bcl2-A1 can physically interact in vitro and in vivo, via 
helix ?9, with pro-caspase-3, preventing its activation. To our knowledge, Bcl2-A1 is the 
only protein inhibitor of caspase-3 able to bind the zymogen precursor and to prevent its 
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caspase-8 mediated activation, since both viral (serpin CrmA and p35) and cellular 
(IAP, inhibitor of apoptosis protein) inhibitors bind the activated formof this caspase 
(Fuentes-Prior and Salvesen, 2004). For instance XIAP (X-linked inhibitor of apoptosis 
protein) is able to bind and inhibit the activated form of caspase-3 while not impairing 
the caspase-8 mediated activation (Deveraux et al., 1997). On the whole, our results 
contribute to the knowledge of molecular mechanisms of action and functional role of 
Bcl2-A1 that have important implications in ALS, where prevention of motor neuronal 
cell death is one of the major therapeutic aims. 
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Theme 2: Biological effects of TDP-43 mutants in neuronal 
cells: implication for ALS 
Accumulations of aggregated proteins are a key feature of the pathology of all of the 
major neurodegenerative diseases. Amyotrophic lateral sclerosis was brought into this 
fold quite recently with the discovery of TDP-43 (TAR DNA binding protein, 43 kDa) 
inclusions in nearly all ALS cases. The identification of TDP-43 mutations in rare familial 
forms of ALS confirmed that altered TDP-43 function can be a primary cause of the 
disease. However, the simple concept that TDP-43 is an aggregation-protein that forms 
toxic inclusions capable of promoting neurodegeneration has not been upheld by initial 
investigations. The aim of this work is the understanding of the relationship between 
TDP-43 aggregation and neurodegeneration, and in particular the relationship between 
aggregates and TDP-43 mutations. Preliminary results, obtained by biochemical 
purification and immunofluorescence, demonstrate that there is not a link between 
aggregates formation and mutants available in my laboratory, or that the formation of 
these aggregates does not depend exclusively by gene mutations. 
 
1. Biochemical properties of TDP-43A382T missense mutation  
It has been demonstrated that purified TDP-43 synthesized in bacteria is highly prone to 
aggregation and rapidly falls out of solution over time, supporting that the protein is 
intrinsically aggregation prone (Johnson et al., 2009). The C-terminal region was 
required for this aggregation tendency, as a fragment of the N-terminus containing only 
the RNA recognition motif (RRM) domains remained soluble. TDP-43 was cleaved into 
C-terminal fragments in the disease state, and became phosphorylated. Electron 
microscopy showed that purified full-length TDP-43 or C-terminal fragments formed 
amorphous aggregates and did not have properties of amyloid. This is akin to the 
properties of inclusions in ALS patient tissues, which likewise appear amorphous and 
non-amyloid. A second study of purified protein supported that the C-terminus of TDP-
43 is critical for aggregation, and found that one particularly aggregation-prone 
subregion could also form amyloid fibrils (Chen et al., 2010). Finally, TDP-43 point 
mutations linked to ALS increased the propensity of purified TDP-43 to aggregate, 
supporting that increased tendency to aggregate may be an important property of ALS 
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associated TDP-43 mutations (Johnson et al., 2009). As reported in the Introduction the 
TDP-43A382T missense mutation accounts for approximately one-third of all ALS cases 
in the Sardinian population (Orrù et al., 2011; Chiò et al., 2010). To gain some 
information about the physiopathological mechanisms of this ALS caused by TDP43 
mutation, I cloned TDP-43 gene in a wild type form, isolated from SH-SY5Y RNA by RT-
PCR, into pCS2-MTK and then mutagenized to obtain pCS2-MTK-TDP-43Q331K, -TDP-
43M337V, -TDP-43A382T, in fusion with myc epitopes.  
 
Fig. 1 Schematic diagram of the TARDBP gene with three of five functional domains : RRM1 and RRM2, 
the two RNA recognition motifs, a glycine-rich C-terminal region with three mutations (Q331K, M337V, 
A382T).  
 
In order to investigate the subcellular distribution of TDP-43A382T I perform an 
immunofluorescence analysis on SH-SY5Y transfected cells. Figure 2 shows that wild 
type TDP-43 is was largely restricted to the nucleus. In some cells, however, 
TDP43A382T was distributed throughout the cytoplasm and the nucleus, with a 
distribution overlapping with the one described for the others TDP-43 mutants (Barmada 
et al., 2010). 
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Fig. 2. Confocal microscopy analysis of SH-SY5Y cells transfected with (A) human TDP-43 wild type or 
(B) human TDP-43Q331K, (C) TDP-43M337V, (D) TDP-43A382T.The immunofluorescence was performed after 
48 h of transient transfection. Antibody anti-myc was used to show the localization of the TDP-43 protein. 
Inside the white circles is showed the partial cytoplasmic redistribution of mutant TDP-43 (Fig. 2B,C,D) 
compared to the wild type protein (Fig. 2A). 
 
The effect of the A382T mutation on protein localization was also evaluated by 
subcellular fractionation (Fig. 3), showing that cells expressing TDP43A382T displayed 
approximately as much cytoplasmic protein as those expressing TDP43WT, TDP43Q331K, 
TDP43M337V. 
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Fig. 3. Cytosolic and nuclear protein extracts were prepared after 48 h of transient transfection of SH-
SY5Y. The presence of TDP-43 protein was assessed by Western blot using anti-myc antibody. is a 
marker of mitochondrial fractions.??-actina was used as a control of protein concentration 
 
I further extend my analysis, by testing the aggregation properties of A382T mutant, 
using a biochemical approach. SH-SY5Y cells were transfected, with the indicated 
plasmid, and the extracted proteins were separated according to their solubility. As 








Fig. 4. Total (TOT), Soluble (Sol.) and insoluble (Insol.) protein extracts were prepared after 72 h of 
transient transfection of SH-SY5Y cells. The presence of Bcl2-A1 protein was assessed by Western blot 
using anti-myc antibody. ?-actina was used as a control of protein concentration. 
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Lanes 6 and 7, 8 and 9 of every Western blot (Fig. 3A,B,C) show that the protein signal 
is very strong in the soluble fraction of wild type and mutant TDP-43, compared to the 
respective insoluble fraction, to indicate that there is not misaccumulation of the protein 
in the insoluble fraction of the wild type protein and in the mutant proteins neither.  
This kind of experiments were performed also in immortalized motor neuron cells (NSC-
34) and the results were comparable to results obtained in SH-SY5Y cells (data not 
shown). 
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Within a few years since the discovery of TDP-43 inclusions in ALS, our knowledge has 
expanded rapidly. I have learned that TDP-43 aggregation is observed in a diverse set 
of neurodegenerative and myodegenerative diseases, not just ALS. Furthermore the 
importance of the C-terminal domain, the location of the majority of the ALS-associated 
mutations, for promoting self-aggregation in addition to mediating protein?protein 
interactions has come to light. Recent studies have pointed to the possibility that TDP-
43 inclusion pathology may reflect an exaggeration of normal accumulation of TDP-43 
into cytoplasmic granules. Finally, while detergent-insoluble inclusions were the key 
feature leading to the connection between TDP-43 and neurodegeneration, existing 
animal models clearly demonstrate that TDP-43 toxicity (at least in the context of 
overexpression) can occur without the formation of TDP-43 inclusions. While somewhat 
disconcerting, the same ambiguous relationship between inclusion formation and 
?????????????????? ??? ????????? ??? ????? ?????? ???????? ??? ?????? ????? ???????? ????????
increased amyloid-? production promotes amyloid plaque formation and synaptic 
dysfunction, but not neurodegeneration (Ashe et al., 2010). By contrast, in 
?????????????? ????????? ??????????? ???????????????? ???????? ???? ????????????? ?????????
toxicity and neurodegeneration do not require inclusion formation, analogous to what is 
observed in TDP-43 model systems (Klement et al., 1998; Saudou et al., 1998)  
Many studies analyze the link between mutations and TDP-43 aggregation, in the same 
way I have started to study this phenomenon, in particular in this study, the role of three 
new TARDBP mutations (Q331K, M337V and A382T) was investigated using SH-SY5Y 
cell line. The data validate that these mutations determine a partial redistribution of the 
protein, compared to the wild type protein, but in neuroblastoma cell line and in 
immortalized motor neuron cells (NSC-34) the expression of mutant TDP-43 did not 
induce toxicity and aggregation was not observed. The molecular mechanism through 
which mutant TDP-43 leads motor neurons to the disease is still not understood and a 
better understanding of the molecular partners of TDP-43 as well as its function in motor 
neurons is required. Therefore, it appears that we are just at the beginning of our 
understanding of the relationship between TDP-43 aggregation, inclusion formation and 
neurodegeneration. Though a challenging topic, an improved understanding of this 
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relationship will be necessary as I consider ways to modulate TDP-43 aggregation for 
potential therapeutic benefit in ALS. 
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